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ABSTRACT
The research in this thesis revolves around developing analytical methods 
for the determination of coumann and 7-hydroxycoumann for various 
applications The techniques used in this work were, capillary 
electrophoresis, immunosensing and electrochemistry Chapter 1 serves as 
general review of the analysis of coumann and 7-hydroxycoumann, 
including the many different types of analytical technique which have been 
used to analyse this drug Capillary electrophoresis was used as the basis 
of a method for the determination of 7-hydroxycoumann in unne and 
serum This method offered advantages over existing technology, due to 
the speed of analysis compared to existing methods Capillary 
electrophoresis was also used to study of the metabolism of coumann by 
liver microsomes This work proved very interesting with a novel method 
being developed for the determination of the mam metabolite of coumann 
in humans This method was also applied to an mterspecies study on the 
metabolism of coumann m a vanety of species, while it also found 
application m tiying to understand some of the different reactions which 
take place in hver microsomes Electrochemistry was used to study further 
some microsome reactions with some success A biosensor was 
constructed for the determination of 7-hydroxycoumann which used 
electrochemical detection An immunosensor based on a competitive 
electrochemical immunoassay was developed The antibody-based 
biosensor employed horseradish peroxidase-labelled anti-7- 
hydroxycoumann, with the enzyme catalysed reaction involving the 
reduction of hydrogen peroxide m the presence of a mediator
XI
CHAPTER 1
ANALYSIS OF COUMARIN AND 7-HYDROXYCOUMARIN
i
1.1 HISTORICAL BACKGROUND
Coumann is a naturally occurring constituent of many plants and essential 
oils, mcludmg tonka beans, sweet clover, oil of cassia and lavender Its 
name is derived froin the plant Coumarouna odorata Coumann (1,2- 
benzopyrene) is of significant clinical importance due to its use m the 
treatment of many diseased states [1,2] It has been used m clinical 
practice, m post-thrombotic syndromes for treatment of vancose vems and 
in post-traumatic oedema Coumann has also been used m cancer therapy 
and has also been found to have an mhibitoiy effect on the induction of 
cancer [3,4]
Voleg isolated and punfied coumann from the tonka bean (Dipteryx 
odorata) in 1822 Later it was synthesised in 1868 by Perkin (m Casley- 
Smith, [5]) By now much information has been generated on its properties 
and potential uses (Table 1 1) Coumann is also known as 2H-1- 
benzopyran-2-one, 1,2-benzopyrone, cis-o-coumanmc acid lactone, 
coumanmc anhydnde, o-hydroxycinnamic acid-8-lactone, and 2-oxy-l- 
benzopyran (reviewed by Cohen [6]) Coumann is a member of a class of 
compounds called benzopyrones Benzopyrones consist of fused benzene 
and a-pyrone rings Coumann can exist as an odourless complex 
conjugated to sugars and acids, which can be broken down by the action 
of enzymes, acids, or ultraviolet (UV) radiation Coumann is also found in 
hay and its presence gives it a charactenstic odour Coumann compounds 
have been used to treat a vanety of ailments such as bums, cancer, 
brucellosis and rheumatic disease
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1.2 PHYSICAL AND CHEMICAL PROPERTIES
The relative molecular mass of coumann is 146 15 and it exists as a solid 
with a pleasant and characteristic odour The meltmg pomt of the molecule 
is 303°C Coumann has a UV absorption maximum at 272 nm in 
chloroform It is freely soluble in ethanol, chloroform and oils, while only 
sparingly soluble m boiling water and only slightly soluble in cold water at 
20°C
1 3 INDUSTRIAL USES
Coumann has many uses in industry, mainly due to its strong fragrant 
odour Its uses include that of a sweetener and fixative of perfume, an 
enhancer of natural oils, such as lavender, a food additive in combination 
with vanillin, a flavour/odour stabiliser in tobaccos, an odour masker m 
paints and rubbers, and finally it is also used m electroplating to reduce ihe 
porosity and increase the bnghtness of vanous deposits, such as nickel 
(Table 1 1) A number of natural synthetic denvatives of coumann exist, 
but only a few are of any commercial importance These mclude 3,4-di- 
hydroxycoumann, mainly used m the perfume industry, 6-methylcoumann, 
used as a flavour enhancer, and 7-hydroxycoumann (7-OHC), used m sun 
screens and fluorescent bnghteners (Table 1 1) Denvatives of 7-OHC are 
also used as fluongemc enzyme substrates 7-amino-4-methylcoumann, 4- 
methyl-umbelliferone, and other coumann denvatives are used as laser 
dyes The most important denvative is 4-hydroxycoumann, which is found
3
in spoiled hay and is a precursor of dicumarol and warfarin, both of which 
are vitamin K antagonists
Compound Toxicity Applications
Coumarm LT Sweetener
Fixative
Flavour stabiliser 
Food additive 
Odour masker 
Electroplatmg
4'Hydroxycoumarin anticoagulant Production of 
dicumarol
Warfarin anti-coagulant Rodenticide 
Cancer therapy
3,4-Di-hydroxycoumann LT Perfume industry
6-Methylcoumarm photo-allergen Flavour enhancer
7-Hydroxycoumann LT Sun screens 
Fluorescent bnghtener
4-Methyl-umbelliferone LT Laser dye
Amino-methyl-coumarm 
acetic acid (AMCA)
LT Fluorescent label
Flavone-8-acetic acid LT Cancer therapy
LT = limited evidence of toxicity
Table 1 1 Properties of coumarm and some of is  common derivatives
\1.4 METABOLISM
Coumann is metabolised initially by a specific cytochrome P450 linked 
mono-oxygenase enzyme (CYP2A6) system m liver microsomes, resulting 
in hydroxylation at positions 7 and 3 Human liver microsomes contam 
high levels of this enzyme compared with activities in the livers of various 
animal species It has been shown that there exists large mter-mdividual 
variability in the activity of this enzyme [7] The possible polymorphism of 
this enzyme in man has been studied in vivo Rautio et al [8] measured 
the urinary excretion of 7-OHC following administration of coumann The 
rate of 7-OHC formation during the first two hours appeared to be vanable 
but stable and reproducible for a given individual Four individuals out of a 
total of 110 were slow metabolisers of 7-OHC However, a larger 
population size would be required to statistically prove that a 
polymorphism exists The corresponding enzyme m mouse liver (CYP2a- 
5) was shown to be strain dependant The human isoform of the enzyme 
has been transfected into mammalian cells via a retrovirus-mediated 
expression system, m order to allow this enzyme to be studied m vitro 
(reviewed by Pelkonen et al [9]
Coumann, having been metabolised to form 7-OHC, then undergoes phase 
II conjugation pnor to excretion (7-OHCG) [10, 11] The most common 
routes of hydroxylation are at positions 7 and 3 to yield 7-OHC and 3- 
hydroxycoumann (3-OHC), respectively 3-OHC can be further 
metabolised, non-enzymatically, by nng splitting to form two further 
products, o-Hydroxyphenyllactic acid (O-HPLA) and o- 
hydroxyphenylacetic acid (O-HPAA) The major phase II metabolite m
5
man is a glucuromde conjugate, 7-OHCG [12] Moran et al [13] showed 
that on average, 63% of a total dose of 200 mg of coumann was 
recovered as 7-OHC in the unne of volunteers over a 24 hour period, with 
most recovered within the first 10 hours Rautio et al [8] showed that 
between 30-100% of an oral dose of coumann was recovered as 7-OHC 
within 4 hours of administration The mam pathways of coumann 
metabolism are shown in Fig 11
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Figure 1.1 Metabolic pathways of coumann in mammals Reproduced 
from references [21,17]
In rats, quite a different metabolic pathway is found , with small amounts 
of 3-OHC (1-2%) and very little 7-OHC formed In rabbits, the major 
metabolites are O-HPAA (18-22%), 3-OHC (18-23%), and 7-OHC (10- 
16%) In addition there are trace quantities of 4-, 5-, 6-, and 8- 
hydroxycoumann [11] In the case of the mouse, there exists a quantitative 
difference between the strains, which is due to differences in isoenzyme 
activity Coumann-7-hydroxylase is much greater m human than rodent 
microsomes, and conversely, coumarm-3-hydroxylase activity is high in 
rodents while absent in human microsomes , (reviewed by Cohen [6]) In 
1991, Huwer et al [14] identified a coumann mercaptunc acid metabolite 
in the unne of Wistar rats This metabolite was thought to have arisen from 
a 3,4-epoxide which was subsequently coupled with glutathione 
In 1983, Ritschel and Hardt [15] showed that the mongolian gerbil 
metabolised coumann in a manner similar to man Unlike most other 
rodent species, the mongolian gerbil forms a large amount of 7-OHC This 
animal has been ^sei ui a model for studying the pharmacology and 
toxicological effects (Dominguez et al [16]) A novel metabolite of 
coumann, o-hydroxyphenylacetaldehyde (o-HPA), was isolated in rat, 
gerbil and human hepatic microsomes following incubation with coumann 
It was also shown that this was a major metabolite in all three sources of 
hepatic microsomes [17] These authors postulated that o-HPA, formed 
from coumann 3,4-epoxide may subsequently give nse to o-HPAA and o- 
hydroxyphenylethanol Fentem and Fry [18] showed that treatment of rats 
with phenobarbitone or p-naphthoflavone increases the amount of o-HPA 
formed Metabolism of coumann by human liver microsomes gave nse to 
o-HPA, 7-OHC, 3-OHC and trace amounts of 5- ,6- and 8-OHC Gerbil 
microsomes metabolised coumann to give 3-, 5-, 6-, 7-, and 8-OHC, and
8
3,7-and 6,7-di-hydroxycoumanns, along with o-HPA They also showed 
that at low coumann concentrations (0-10 jJVT), hepatic microsomal 
metabolism in gerbil resembled that m man, with 7-OHC being the major 
metabolite, but with O-HPA levels being greater in the gerbil than in the 
human They concluded that the gerbil was a more appropriate annual 
model than the rat for comparison with the human
1.5 PHARMACOKINETICS
It has been demonstrated by Waller and Chasseaud [19], that the 
pharmacokinetic profile of coumann in baboons was similar to that in man 
The very high levels of 7-OHCG m plasma indicated that all of the 
coumann was absorbed from the gut and distnbuted not only to organs 
with high blood flow, but also to the extracellular fluid and intracellular 
compartments of other tissues
Coumann is often considered a pro-drug due to its rapid metabolism to 
form 7-OHC This theory has been partially substantiated, since coumann 
has a short half-life Shanfi et al [20] showed that following large oral or 
intravenous doses, coumann was rapidly metabolised to form 7-OHC and 
7-OHCG They found that plasma concentrations of 7-OHC were about 
ten times lower than 7-OHCG In urine 7-OHCG was the main metabolite 
with a recovery of one third of the initial dose 7-OHC is lipophilic, 
preventing its renal excretion and leading to its presence in the plasma 
They concluded that 7-OHC, and not coumann, was the pharmacologically 
active agent
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1.6. TOXICOLOGY
The Food and Drug Administration (FDA) banned the use of coumarm m 
1954 Previously it had been used in foodstuffs, and smce then there has 
been an on-gomg dispute over its toxicity The data on which the FDA 
made their decision was derived mainly from animal studies usmg rats 
The preliminary results from these studies indicated that coumann was a 
toxin, but it has been shown smce that the rat is a poor model to compare 
with the human for this particular drug metabolism
1.7 ANALYSIS QF COUMARIN AND COUMARIN-RELATED
COMPOUNDS
Many techniques have been used to analyse coumarm and coumann- 
related compounds The two techniques that have been the most widely 
used are, high performance liquid chromatography (HPLC) [8, 13, 21-23] 
and spectrofluonmetry [8, 24, 25] Other techniques that have been used 
mclude paper chromatography [26, 27], thin layer chromatography [28, 
29], gas chromatography with mass spectrometnc detection [30, 31], 
radio-labelling [10, 15, 32, 33], luminescence [34], polarography and 
voltammetry [35, 36, 37] and usmg an amperometnc biosensors [38]
These techniques have been developed for the quantitative and qualitative 
determination of coumarm and coumann denvatives They have been used 
in the analysis of a vanety of samples, including urine, plasma, serum,
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blood, tissue homogenates, and plant material Sample preparation vanes 
greatly depending on the method of analysis used The range of techniques 
used for the analysis of coumann and coumann-related compounds and the 
samples analysed will be discussed m greater detail below
1 7 1 HIGH PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC)
The UV spectra of coumann m tns buffer is shown m Fig 12 Many 
HPLC methods have been developed for the separation and quantitation of 
coumann and its metabolites The first such method was descnbed m 1980 
by Walters et al [21] The HPLC system consisted of a reversed-phase 
Partisil-10 ODS 2 column, with a flow rate of 2 ml/mm, and UV detection 
at 274 nm The separation required a two-stage linear gradient using 
tetrahydrofuran water acetic acid The linear gradient steps were from 
9 7% - 12 8% and then to 20% tetrahydrofuran This gradient run 
produced a good separation of a range of coumann denvatives These 
mcluded o-hydroxyphenylacetic acid (o-HPAA), 8-OHC, 7-OHC, 6- 
OHC, 5-OHC, 4-OHC, 3-OHC, coumann, and o-coumanc acid One of 
the drawbacks to the method was the high flow rate, which resulted in high 
back pressure The total time required to separate all of these denvatives 
was approximately 65 min Walter et al also attempted to extract and 
quantify coumann and its metabolites from tissue incubates However this 
was unsuccessful smce it was impossible to use a single solvent to extract 
compounds with such widely varying polanty
n
Fig 1 2 UV spectra of coumann in tns buffer
The method above, developed by Walters et al [21], was later used by 
Lake et al [39] for comparing the metabolism and disposition of coumann 
m the rat and marmoset In this study, however Lake et al were able to 
quantify coumann, o-HPAA, 3-OHC, o-coumanc acid, 7-OHC and 7- 
OHCG in unne This method was used to show that both the rat or 
marmoset were unsuitable as an animal model for studying the metabolism 
of coumann m man
In 1987, a new method was developed by Moran et al [13], which was 
capable of resolving and quantifying coumann, 7-OHC and its glucuromde 
conjugate (7-OHCG) This method used a reversed-phase Qg ^Bondapak
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column, with a mobile phase of methanol water acetic acid (40 60 0 2), 
and a flow rate of 2 ml/nun Compounds were detected using a fixed 
wavelength detector at 280 nm The use of methanol and the high flow rate 
again caused high back pressure, however, this method was successfully 
apphed to the analysis of urine samples Unfortunately, the method of 
sample preparation was time consuming and cumbersome The urine 
samples were freeze dried and later evaporated, leading to an assay tune of 
approximately 24 hours P-Glucuromdase was used to hydrolyse 7-OHCG, 
to yield free 7-OHC This incubation added 16 h to an already long assay 
time The retention tunes of 7-OHC and coumann were 7 and 10 mm, 
respectively This assay was successfully used to determine the percentage 
of coumann recovered within a 24 hr penod, following oral administration 
It was also used to determine the urinary excretion profile m man, 
following oral administration of coumann
Egan and O’Kennedy [40] descnbed a HPLC method for the determination 
of coumann, 7-OHC and 7-OHCG m unne and plasma The authors 
descnbed the use of a Waters fxBondapak Cis column, a fixed wavelength 
of 324 nm and a mobile phase of methanol water acetic acid (30 70 0 2), 
with a flow rate of 2 ml/nun This method was a significant improvement 
on the method of Moran et al [13] above, as the sample preparation time 
was considerably reduced, although analyte extraction was still required 
Figure 1 3 shows the separation of coumann, 7-OHC and internal standard 
achieved by the method of Egan and O’Kennedy
21
min
Fig 1 3 Separation of (1) 7-OHC, (2) internal standard and (3) coumann 
by HPLC Reproduced from reference [40]
Thompson and Hoffmann [22] showed the presence of coumann m vanilla 
flavoring products, usmg HPLC Separation was earned out usmg a
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yBondapak Cis column, with a mobile phase of methanol water (40 60) 
and a flow rate of 1 ml/min This was a similar HPLC system to that used 
by Moran et al above, but a lower flow rate was employed Coumann and 
the other derivatives (4-hydroxybenzaldehyde, vanillin and ethyl vanillin) 
were momtored at 275 nm No sample extraction was used, but merely 
dissolution m methanol water (50 50) This HPLC method offered a fast 
assay for quantifying coumann m vanilla products
A HPLC method, able to separate and quantify 7-OHC, was then 
developed by Rosenberg et al [23] The mam objective of this method 
was to determine the activity of ethoxycoumann o-deethylase in tissue 
samples o-Deethylase breaks down 7-ethoxycoumann to form 7-OHC, 
which is fluorescent Therefore , the method was based on fluorescence of 
7-OHC in alkaline solution Ethoxycoumann o-deethylase was isolated 
from cells with low levels of cytochrome P-450, that would otherwise be 
below detection The method used a reversed-phase Nova-pak Cg column, 
with a mobile phase of methanol 1% acetic acid, (35 65), at a flow rate of 
1 ml/nun Samples were extracted with chloroform and were then 
separated on the HPLC column 1 N sodium hydroxide was added to the 
post-column eluate 7-OHC was detected usmg a fluorescence detector, 
with excitation and emission wavelengths of 368 and 456 nm respectively 
This method has been improved by Evans and Relling [41] They 
automated the system and used 4-methyl-umbelhferone as an internal 
standard
In 1991, Huwer et al [14] developed a HPLC method for the separation 
and quantitation of coumann mercaptunc acid This new denvative was
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isolated from rat urine and indicated that an epoxide of coumann had been 
formed during metabolism This method was able to separate and quantify 
o-hydroxyphenyllactic acid (o-HPLA), o-HPAA, 7-OHC, coumann-3- 
mercaptunc acid, coumann, 3-OHC and o-coumanc acid Separation of 
these compounds was earned out using a reversed-phase Sphensorb ODS 
2 column, with a mobile phase of water THF acetomtnle acetic acid 
(764 100 85 50), at a flow rate of 1 ml/nun, and detected at 285 nm 
Samples were prepared by washing in acetone methanol water (3 11) and 
concentrated pnor to analysis The total time required for separation and 
elution of all the coumann metabolites was 30 mm
Fentem et al [17] and Fentem and Fry [18] examined the metabolism of 
coumann by rat, gerbil and human liver microsomes They used a HPLC 
method based on the method developed by Vande Casteelle et al [42] 
This method was able to separate a range of coumann metabolites, 
including 6,7-di-hydroxycoumann, 6-OHC, 7-OHC, 8-OHC, 5-OHC, o- 
coumanc acid, 3-OHC, coumann and 4-OHC A new metabolite of 
coumann, o-hydroxyphenylacetaldehyde, formed in rat liver microsomes, 
was also detected An external standard of 7 -methoxy-coumann was used 
Separation was earned out usmg a reversed-phase Sphensorb 5 ODS 2 
column, with 2 stage linear gradient elution The mobile phases used were 
formic acid water (5 95) and methanol Coumann compounds were 
detected at 280 nm All of the metabolites were well separated and eluted 
within 22 mm
A relatively new HPLC method developed Rautio et al [8], based on the 
method of Fasco et al [43], was used to measure 7-OHC and its
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glucuromde in human unne This method was used by Rautio et al [8], to 
show that there is great mter-mdmdual variability m the extent and rate of 
7-OH-C formation Unne was treated with p-glucuromdase, filtered and 
analysed by HPLC Separation was earned out using a Nucleosil Cig 
column The mobile phase used was 20 % of 1 5 % (v/v) acetic acid, pH 
4 85 (Buffer A) and 80 % of buffer B (Buffer A and 50% acetomtnle) A 
flow rate of 1 ml/nun and detection wavelength of 313 nm were used The 
assay could be earned out very quickly, since veiy little sample 
preparation was required and the retention tune of 7-OH-C was 5 mm
1 7 2 FLUOROMETRIC METHODS
Tan et al [24] developed a spectrofluorometnc method for the 
determination of coumann and 7-OH-C The analysis of coumann was 
based on the irradiation of compound m alkaline solution with UV light 
This converted coumann from the cis-to the trans -isomer, leading to the 
formation of a fluorophore The fluorophore showed excitation and 
emission wavelengths of 361 and 491 nm, respectively This 
spectrofluorometnc method was used to quantify coumann and 7-OH-C in 
whole blood following two solvent extraction’s with diethyl ether The 
method was shown to be reproducible, sensitive and free from 
interferences However, one of the major drawbacks of this method was 
the substantial time required for sample preparation pnor to analysis 
Hence, this method had a long assay time Also, it did not desenbe a 
method for the hydrolysis of 7-OHCG
17
In 1981, Ritschel et al [44] used the method developed by Tan et al [24] 
to determine the apparent partition coefficient, pKa, and protein and 
erythrocyte binding of 7-OHC Ritschel and Hardt [15] again used this 
method m order the concentration of coumarm, 7-OH-C, and 7-OHCG m 
blood and brain of gerbils The tissue was prepared by protem 
precipitation and homogemsation This modification of the method of Tan 
et al proved to be very successful in determining the pharmacokinetics of 
coumarm and its metabolites The results indicated that the gerbil was a 
suitable animal model for studying coumarm metabolism
A modification of the method developed by Tan et al was used by Rautio 
et al [8] m order to determine the concentration of 7-OH-C and 7-OHCG, 
m human unne and serum Following hydrolysis of 7-OHCG, a sample 
was extracted with chloroform and diluted with 1 M sodium chloride 0 01 
M sodium hydroxide The fluorescence m the alkaline phase was measured 
immediately usmg a spectrofluonmeter, at excitation and emission 
wavelengths of 365 and 454 nm, respectively The method was shown to 
be both accurate and precise, and having a limit of detection of 0 5 nM
Egan and O’Kennedy [25] then developed a sensitive spectrofluonmetnc 
assay for the determination of 7-OHC in unne and plasma Urinary 
concentrations of free, total and conjugated 7-OHC were determined 
Samples were extracted with diethyl ether and a suitable aliquot of 
reconstituted extract diluted m phosphate buffered saline, and transferred 
to a 96-well microtitre plate The fluorescence intensity was determined at 
excitation and emission wavelengths of 370 and 450 nm, respectively 
Linear ranges of 7-OHC m unne and plasma were found to be 0 5-10 and
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10-100 ng/ml The method was an improvement on the previously 
described method of Tan et al [24]
1 7 3 OTHER TECHNIQUES
A variety of other methods for the analysis of coumann and 7-OHC have 
been developed These include paper chromatography, TLC, gas 
chromatography with mass spectrometnc detection, capillary 
electrophoresis, radio-labelling, luminescence, polarography and 
voltammetry and amperometnc biosensor detection
17 3 1 Paper chromatography
Paper chromatography was used by Booth et al [26] as a method for the 
analysis of coumann in the unne of rat and rabbit Several metabolites of 
coumann, including o-HPAA, o-HPLA, -hydroxyphenylhydrarylic acid, o- 
coumanc acid, 7-OHC, 4-OHC and 3-OHC were separated o-HPAA, 3- 
OHC and 7-OHC were extracted from rabbit unne using ethanol and later 
with carbon tetrachlonde followed by chloroform The other metabolites 
were extracted from unne using diethyl ether and separated using two 
dimensional paper chromatography Separation was earned out using a 
solvent system of chloroform acetic acid water (2 1 1) m one dimension 
and then 20% (w/v) aqueous potassium chlonde, in the second 
Identification was achieved usmg a set of authentic standards on the basis
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of Rf values, behaviour under UV light, and colour after spraying with 
diazotised sulphamlic acid This method was used to identify a new 
metabolite of coumann, o-HPAA, in both rat and rabbit urine The method 
was found to be qualitative but not quantitative
Another paper chromatographic method was developed by Van Sumere et 
al [27] in 1959 The metabolites of coumann m urrne taken from normal 
patients and those suffering from vanous pathological conditions The 
samples were examined using circular paper chromatography The samples 
were extracted using either diethyl ether or ethyl acetate The extraction 
procedure was long and cumbersome and required a great deal of 
preparation In order to separate all of the coumann metabolites, two 
solvents were used Usmg the first system, the extracts were applied to 
filter paper and separated usmg petroleum ether and later chloroform, 
saturated with formamide The second system used a solvent system of 
petroleum ether, and later butanol water (4 1) Identification was based on 
the Rf values, colour reactions and appearance under UV light The 
method identified trace amounts of 7-OHC and 6,7-dihydroxycoumann m 
normal unne It also showed large quantities of 7-OHC m the unne of 
patients receiving prednisone treatment This method, like the previous 
one, was unable to quantify the vanous metabolites detected
1 7 3 2 Thin layer chromatography
Sherma et al [28] developed a method that could determine coumann in 
vanilla flavourings usmg high performance silica gel TLC This method 
allowed coumann be determined both qualitatively and quantitatively
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Coumann was separated on pre-treated silica gel plates using a solvent 
system of toluene methanol (97 3) Coumann was then detected by 
spraying the plates with 5-10 % (w/v) sodium or potassium hydroxide and 
viewed using fluorescence long wave UV light (360 nm) The plates were 
also sprayed with diazotised sulphamlic acid reagent in order to produce a 
coloured product The plates were then scanned for their fluorescence and 
depth of colour using densitometry The peak area was calculated and 
allowed the concentration of coumann in vanilla samples to be determined 
The method had one disadvantage, since both fluorescence and colour 
changed m intensity with time
Recently a novel TLC method with fluorescence detection was developed 
by Cholerton et al [29] for the determination of 7-OHC in human urine 7- 
OHC was extracted using chloroform and evaporated A sample of dned 
extract was applied to a TLC plate and separated usmg a solvent system of 
chloroform water ethyl acetate acetic acid (24 12 6 0 5) The plates were 
then scanned at 313 nm usmg a mercury lamp The peak height was 
determined and used to construct a calibration curve p-glucuromdase was 
also used to hydrolyse 7-OHCG The method proved to be sensitive, 
accurate, precise and more selective for the analysis of 7-OHC when 
compared to the spectrofluorometnc method of Greenlee and Poland [45]
1 7 3 3 Gas chromatography with mass spectrometnc detection
In 1980, a gas chromatographic method with mass spectrometnc detection 
(GC-MS) was used by Legrum and Netter [30] to identify the vanous di- 
hydroxylated metabolites of coumann, formed by pre-treatmg mice with
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cobalt Coumann and 7-OHC were incubated with isolated microsomes 
from these animals Diethyl ether was used to extract the samples The 
concentrated extract was methylated usmg diazomethane, which was 
followed by preparative TLC This method used two solvent systems, the 
first being benzene, followed by methanol The relevant area was removed 
and analysed by GC-MS This work showed that pre-treatment with cobalt 
gave rise to di-hydroxylated metabolites of 7-OHC
Vnes et al [31] analysed extracts from justicia pertoralis usmg GC-MS 
This plant is used by Indians in the Amazon m tribal medicine The 
compounds had first to be denvatised with diazomethane and separated 
usmg capillary GC-MS The retention times and mass spectral data were 
compared with those of standard compounds The results suggested the 
presence of both coumann and 7-OHC
1 7 3 4 Capillary Electrophoresis
There has been a number of publications dealing with the analysis of 
coumann and its denvatives by capillary electrophoresis [46-50] 
Recently, Bogan et al [46] have reported on the direct determination of 7- 
OHC and 7-OHCG in urine without any sample clean-up Separation was 
earned out in 90% 100 mM L"1 phosphate buffer, 11 mM L'1 deoxychohc 
acid and 10% acetomtnle on a 47 cm uncoated silica capillary, at 20 KV, 
with detection of the analytes at 320 nm This method has a considerable 
advantage over existing chromatographic methods m that no sample 
preparation was necessary. The separation of 7-OHC and 7-OHCG by this 
method is shown m Figure 1 4
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Fig 1 4 Electropherogram showing the separation of (A) solvent front, 
(B) 7-OHC and (C) 7-OHCG in urine analysis Reproduced from reference
[46]
In 1993, Morin and Dreux [47] reported on factors influencing the 
separation of lomc and non-iomc chemical natural compounds m plant 
extracts by capillary electrophoresis Micellar electrokinetic capillary 
chromatography (MECC) based on sodium dodecylsulfate (SDS) and 
cetyltnmethylammomum chloride (CTAC1) micelles was developed for the 
separation of uncharged natural compounds (coumann derivatives) or
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charged solutes (phenolic carboxylic acids) The high efficiency 
separations allowed the resolution of closely related compounds The 
coumann derivatives were separated usmg an applied voltage of 18 kV on 
a 70 cm x 50 (j.m l d silica capillary The buffer used was a phosphate- 
borate buffer /0 1 M SDS pH 7 0 A wavelength of detection of 195 nm 
was used Upto 7 coumann denvatives were separated in under 20 mrns
Further to the above capillaiy electrophoresis methods, Chen and Sheu 
have descnbed another method for the separation of coumanns by MECC
[48] Dhulst and Verbeke [49] have descnbed the separation of the 
enantiomers of coumanmc acid anticoagulant drugs by capillary 
electrophoresis usmg maltodextnns as chiral modifiers, and Ochocka et al 
[50] have reported work on the determination of coumanns from 
chrysanthemum segetum by capillary electrophoresis
1 7 3 5 Radio-labelling Methods
Kaighhen and Williams [10] and Feuer et al [32] used radio-labelled 
coumann to study the metabolism and excretion of coumann m rats The 
coumann molecule was labelled at 14C m the third position (3-14C- 
coumann) and administered orally The results indicated that both the 
urinary and faecal routes were important m the excretion of coumann m 
the rat Van Sumere and Teuchy [33] then studied the excretion of 
coumann in expired air usmg radio-labelled coumann Rats were 
administered radio-labelled coumann by mtra-pentomal injection Radio-
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labelled CO2 was detected m the expired air, resulting from 
decarboxylation of an intermediate precedmg the formation of o-HPAA
In 1983, Ritschel and Hardt [15] also used 14C-labelled coumann (3-14C- 
coumann) and 7-OHC to detemune their distribution in mice Blood and 
tissue samples were extracted by solvent extraction using diethyl ether A 
beta counter was used to determine the total radioactivity Analysis was 
also earned out using TLC and compared to reference standards From 
these studies it was concluded that the hver and kidney contained the 
highest levels of radioactivity following administration with both 
compounds
1 7 3 6 Luminescence
Total luminescence spectroscopy has been used by Shanahan et al [34] 
for the detection and identification of coumann in road fuels The method, 
which was used was similar to that desenbed by Tan et al [24] Coumann 
m the fuel was converted from the as- to the trans-isomer, following 
exposure to UV radiation at 366 nm 3-D spectra were obtained by 
running successive emission scans from 320 to 600 nm, with excitation 
wavelength from 300 to 400 nm The scans that resulted were compared to 
reference standards This method was found to qualitative but not 
quantitative
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1 7 3 7 Polarography and Voltammetry
A polarographic method for the determmation of coumann m sweet clover 
herbage was developed by Orlov [35] Coumann had to be extracted from 
boiling ethanol and added to a solution of tetraethylammomum iodide 
before analysis The method proved to be both quantitative and selective
Carrazon et al then [36] developed a voltammetnc method for the 
determmation of 7-OHC and 7-hydroxy-4-methylcoumann A glassy 
carbon electrode was used for this work m micellar solution and emulsified 
medium No solvent punfication was required as the medium used was 
mainly aqueous The results showed this method to be highly sensitive, 
which could also be used quantitatively
Dempsey et al [37] then reported on the electrochemical behaviour of 7- 
OHC at the bare glassy carbon electrode usmg differential pulse 
voltammetry Based on anodic detection of this metabolite at 0 66V (v’s 
SCE) usmg DC amperometry, a method was developed for the 
determmation of 7-OHC levels m unne samples, and a pharmacokinetic 
profile was descnbed
1 7 3 8 Amperometnc Biosensor Detection
Following the previous study usmg DC amperometry at a bare glassy 
carbon electrode, Dempsey et al [38] developed an amperometnc 
biosensor, based on an anti-7-OHC-antibody immobilised at the surface of
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a glassy carbon electrode, and contained behind a cellulose dialysis 
membrane The electrochemical behaviour of this metabolite at the bare 
glassy carbon electrode was found to be well defined usmg differential- 
pulse voltammetry, and a 90% decrease m peak height was observed on 
binding of the antibody to the antigen, which occurred at the electroactive 
site of the 7-OHC This system provided a novel method for studying 
antibody specificity and the kinetics of such antibody-antigen interactions
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CHAPTER 2
DETERMINATION OF FREE AND TOTAL 7- 
HYDROXYCOUMARIN IN URINE AND SERUM BY 
CAPILLARY ELECTROPHORESIS
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2.1 INTRODUCTION
Jorgenson and Lukács [1-5] were the first to perform capillary zone 
separations The principle of the method is simple but its realisation 
encountered a number of difficulties The separation is earned out m a 
fused-silica capillary (less than 100 jxm ID )  with a voltage of 10-30 KV, 
applied over a 50-100 cm capillary [6] The separation is obtained by 
differential migration of solutes m an electncal field In High Performance 
Capillary Electrophoresis (HPCE), electrophoresis is performed m narrow- 
bore capillanes, typically 25 to 75 ^un inner diameter (l d ), which are 
usually filled only with buffer [7] Most commonly 20-50 mM buffers of 
both basic and acidic pH can be used, although high pH buffers are 
preferred in order to eliminate capillary wall charge and prevent eg  
separated protem species from adhering to the capillary wall [6]
Use of the capillary has numerous advantages, particularly with respect to 
the detrimental effects of Joule heating The high electncal resistance of 
the capillary allows the application of high electncal fields (100 to 500 
V/cm) with only minimal heat generation Also, the large surface area-to- 
volume ratio of the capillary efficiently dissipates the heat that is 
generated The use of the high electncal fields results m short analysis 
times and high efficiency and resolution Peak efficiency, often in excess 
of 10s theoretical plates, is due m part to the plug profile of the 
electroosmotic flow, an electrophoretic phenomenon that generates the 
bulk flow of solution within the capillary [7] This flow enables the 
simultaneous analysis of all solutes, regardless of charge In addition the 
numerous separation modes, which offer different separation mechanisms
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and selectivities, minimal sample volume requirements (1 to 10 nl), on- 
capillary detection, and the potential for quantitative analysis and 
automation, HPCE is rapidly becoming a premier separation technique 
[6,7]
The overall simplicity of the instrumentation is one key feature of HPCE 
The early attempts to obtain capillary zone electrophoresis (CZE) 
separations were invariably done with laboratory-made equipment, 
however, numerous types of instruments are commercially available now 
e g Microphoretic Systems, Applied Biosystems, Bio-Rad Labs, 
Beckman Instruments and Dionex [6] The design and operation of most 
instruments is very similar, briefly, the ends of a narrow bore fused silica 
capillary are placed m buffer reservoirs The content of the reservoirs is 
identical to that within the capillary The reservoirs also contain the 
electrodes used to make electrical contact between the high voltage power 
supply and capillary Sample is loaded onto the capillary by replacmg one 
of the reservoirs (usually at the anode) with a sample reservoir and 
applying either an electnc field or an external pressure After replacmg the 
buffer reservoir, the electnc field is apphed and the separation performed 
Optical detection can be made at the opposite end, directly through the 
capillary wall [7]
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2 1 1 THEORY
Separation by electrophoresis is based on differences in solute velocity in 
an electric field When an electric field is applied across a capillary filled 
with an ionic solution, anions are found to migrate towards the anode, 
whilst cations move towards the cathode [8] The velocity of migration, 
Yep, is related to the potential field strength, E, by the equation
ep MepE (2 1)
where m, is the electrophoretic mobility of a solute This equation can also 
be expressed as
Vep =  HepV/L (2 2)
i
where L is the effective length of the capillary The time taken for a solute 
to migrate through the capillary under an applied field is given by
t = L / Vep = L2 / HepV (23)
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This equation predicts that short columns and high voltages will lead to 
fast analysis times [8] As a solute migrates through a capillary, molecular 
diffusion occurs, and assuming that this is the only source of band 
broadening taking place, then the dispersion a 2, is given by the following 
equation
cr2 = 2Dt = 2DL2 / (iepV (2 4)
where D = diffusion coefficient of the solute The number of theoretical 
plates is now given by
N = L2 / CT2 = MepV / 2D (2 5)
t■
Equations 2 2 and 2 4 predict that operation at high voltages will yield 
highly efficient analyses, within very short run tunes [8] but there is a limit 
to the voltage that can be used, due to problems that arise from Joule 
heating
A fundamental constituent of HPCE operation is electroosmotic, or 
electroendosmotic flow (EOF) EOF is the bulk flow of liquid m the 
capillary and ts a consequence of the surface charge on the interior 
capillary wall The EOF results from the effect of the applied electric field
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on the solution double-layer at the wall The EOF controls the amount of 
time solutes remain in the capillary by superposition of flow on to solute 
mobility [7]
Under aqueous conditions most solid surfaces possess an excess of 
negative charges This can result from ionisation of the surface (that is, 
acid-base equilibria) and/or from adsorption of lomc species at the surface 
For fused silica both processes probably occur, although the EOF is most 
strongly controlled by the numerous silanol groups (SiOH group that can 
exist m anionic form SiO ) on the surface Although the exact pi of fused 
silica is difficult to determine, EOF becomes significant above pH 4 0 [7]
Countenons (cations, in most cases), which build up near the surface to 
maintain charge balance, form the double-layer and create a potential 
difference very close to the wall This is known as the zeta potential 
When a voltage is applied across the capillary the cations forming the 
diffuse double-layer are attracted toward the cathode Because they are 
solvated, their movement drags the bulk solution m the capillary toward 
the cathode This is shown in Figure 2 1
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Fig 2 1 Development of the electroosmotic flow (a) negatively charged 
fused silica surface (Si-O ), (b) hydrating cations accumulating near the 
surface, and (c) bulk flow towards the cathode on application of an 
electrical field (Reproduced from reference [7])
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One unique feature of electroosmotic flow in a capillary is that it is plug- 
like and does not have the characteristic parabolic flow profile associated 
with pressure driven liquids [8] The resultant flat flow profile is beneficial 
since it does not directly contribute to the dispersion of the solute zones
Another benefit of the EOF is that it causes movement of nearly all 
species, regardless of the charge, m the same direction Under normal 
conditions (that is, negatively charged capillary surface), the flow is from 
the anode to the cathode Anions will be forced towards the cathode smce 
the magnitude of the flow can be more than an order of magnitude greater 
than then electrophoretic mobilities [7] Thus cations, neutral species, 
and anions can beelectrophoresedm a single run smce they all “migrate” 
m the same direction This is shown in Fig 2 2 Here, cations migrate 
fastest, smce both the electrophoretic attraction towards the cathode and 
the EOF are m the same direction, neutrals are all earned at the velocity of 
the EOF but are not separated from each other, and anions migrate 
slowest smce they are attracted to the anode, but are still earned by the 
EOF toward the cathode
Fig 2 2 Differential solute migration superimposed on electroosmotic flow 
m capillary zone electrophoresis (Reproduced from reference [7])
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2 1 2 REVIEW OF CAPILLARY ZONE ELECTROPHORESIS IN
BIOMEDICAL ANALYSIS
In recent years the number of publications involving capillary 
electrophoresis has increased steadily, and many reviews have been 
published in this field [6, 8-12] Capillary Electrophoresis has found 
application across the full spectrum of pharmaceutical and biomedical 
analysis
The equation for separation efficiency (N) given in equation 2 5 above 
takes mto account the applied voltage (V), electrophoretic mobility (jiep) 
and the diffusion coefficient of the solute (D) With large molecules such 
as high molecular weight proteins, D is small, which means that very high 
efficiency separations can be achieved Although classical electrophoresis 
has been the traditional separation method for large biological molecules, 
difficulties are encountered because proteins can adsorb onto the surface 
of fused silica [8] As a consequence, a lot of effort has gone mto the quest 
for ways of overcoming this problem One way of tackling the problem is 
to use a running buffer at a pH higher than that of the isoelectric pomt of 
the protein, whereby both the capillary surface and the protem carry 
negative charges, so that coulombic repulsion will take place thus 
minimising adsorption of the protem onto the capillary wall Another 
approach (and a more popular one) is to deactivate the capillary surface 
Hjerten [13] reported the bonding of a-methacryloxy- 
propyltnmethoxysilane to the surface of fused silica, m order to eliminate 
electroosmosis This m turn stencally prevented analytes from interacting 
with the capillary wall, reducing adsorption Smce the work reported by
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Hjerten, there have been many papers describing variants of this approach, 
for example, Brum et al [14] modified the capillary surface by first 
coating a-glycidoxypropyltnmethoxysilane and then opening the resultmg 
epoxide group by reactmg with polyethyleneglycol-600 to give highly 
reproducible and stable capillaries These capillaries were then used to 
separate mixtures of protems A different approach was taken by Widhalm 
et al [15], who descnbed the separation of protems usmg a non-cross- 
linked polyacrylamide gel It was shown that the test protems myoglobuhn, 
ovalbumin and bovine serum albumin eluted as their SDS complexes m 
order of mcreasmg molecular mass
The separation of nucleic acids and then fragments represents another 
challenging field for CZE Dolnik et al [16] earned out a thorough 
investigation of vanous parameters affecting the separation of 
oligonucleotides With polycytidines as model compounds, it was 
demonstrated that vanations m pH between 5 and 8 and of lomc strength 
between 20 and 100 mM had little effect on the separation but if the 
background electrolyte also contained SDS and spermine, the separation 
order is considerably affected Heiger et al [17] attempted high 
performance capillary electrophoretic separations usmg gel capillary 
columns of fluorescence-labelled single-stranded oligonucleotides for 
DNA sequencing There are indications that HPCE polyacrylamide gel- 
filled capillaiy columns are probably better suited to DNA sequencing than 
CZE separations [18]
43
Capillary zone electrophoresis plays an important role within the analytical 
laboratory of most pharmaceutical companies because it is complementary 
to the most popular analytical technique of all, high performance liquid 
chromatography There is an abundance of applications m the literature 
describing the analysis of small pharmaceutical compounds Several 
workers m this area use micellar electrokmetic chromatography (MEKC) 
This is a hybrid of electrophoresis and chromatography [7], and is one of 
the most widely used HPCE modes Its mam strength is that it is the only 
electrophoresis technique that can be used for the separation of neutral 
solutes as well as charged ones Fujiwara et al [19] were able to resolve 
seven water soluble vitamins m approximately 25 minutes using 0 02 M 
phosphate pH 9 0-0 05 M SDS as the electrolyte Detection was by UV 
absorption at 254 nm The MEKC method employed was used to 
determine the contents of a vitamin injection and was found to be highly 
accurate and reproducible and was much simpler than the existing gradient 
HPLC method
Wainwnght [20] reviewed the separation of phahnaceutical compounds 
using CZE with both coated and uncoated capillaries Coated capillaries 
used for these studies were prepared by coating with polyacrylamide A 
study of the effect of using coated and uncoated capillaries was undertaken 
usmg both positively and negatively charged compounds This study found 
that the uncoated capillaries were more suited for work in this area, as it 
was possible to elute positive and negative analytes in one run
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Perrett and Ross [21] have reported on the rapid determination of drugs m 
biofluids by capillary electrophoresis, with an example made of the 
measurement of antipynne m saliva for pharmacokinetic studies
CZE is also used in the analysis of chiral molecules Although gas 
chromatography, and particularly HPLC have been used successfully in the 
past, CZE is now beginning to play an important role m the analysis of 
chiral molecules because of the extraordinary efficiencies achievable 
Chiral recognition is achieved by the addition of a chiral selector to the 
electrolyte and examples of the types commonly used are (1) Cyclodextnns 
(n) Crown ethers and (111) Chiral surfactants [8]
Naylor et al [11] have discussed the monitoring of drug metabohsm by 
capillary electrophoresis The authors discuss the use of CE in the study 
of the reactivity of drug metabolites, analysis of biological samples and the 
problems associated with analysis m complex biological matrices The 
authors pomt out that the separation by CE of metabolites that are present 
in complex biological matrices, eg  microsomal preparations, blood 
(plasma and serum) and unne, presents a considerable analytical 
challenge They suggest that, m part, this is due to the low concentration of 
the analytes present, as well as the complexity of the biological matrix, 
which generally contains a multitude of proteins, as well as numerous 
types of other components Such protems have been documented to have 
caused two problems (1) drug metabolites adhere to protein surfaces, and 
hence cannot be separated by CE, and (2) protein introduced onto a 
capillary coats the wall, leading to analyte loss Various approaches have 
been adopted to overcome such problems, including traditional sample
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clean-up methods, such as hquid-liquid or sohd-phase extraction pnor to 
analysis by CE
The purpose of this study was to develop a CE method for the 
determination of free and total 7-OHC in urrne and serum, with the 
intention of reducmg the separation tune needed m comparison to more 
traditional methods, for example those based on HPLC The following 
sections describe how the separation was developed, optimised and 
applied to metabolic studies involving urrne and serum
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2.2 EXPERIMENTAL
221 CHEMICALS
7-Hydroxycoumann and the internal standard, 3-(<x-acetonylbenzyl)-4- 
hydroxycoumann, were purchased from Sigma (St Louis, MO, USA) 
KH2PO4, and K2HPO4 were obtained from Riedei-de Haen (Hanover, 
Germany) 7-hydroxycoumarm standards were prepared from a 1 mg/ml 
stock solution in methanol (HPLC grade, Labscan, Dublin, Ireland)-deiomsed 
water (10 90, v/v) Serial dilution’s of the 7-hydroxycoumann (10 to 500 
Hg/ml) were prepared in deionised water A 1 mg/ml stock solution of the 
internal standard was prepared in methanol for the analysis of free 7- 
hydroxycoumann The electrolyte solution used was 0 025 M phosphate 
buffer (pH 7 5), which was prepared fresh daily by preparing 0 02 M K2HP04 
and 0 005 M KH2PO4 in deionised water
2 2 2  SAMPLE PREPARATION
Control urine was obtained from a volunteer who had not been treated with 
coumann or 7-hydroxycoumann Urine from two volunteers, who had been 
treated with 100 mg coumann, was obtained at specific time intervals (0, 2, 6, 
10, 14 and 24 hr) The unnary volumes were recorded Control serum was 
obtained from St James' Hospital, Dublin It was not possible to analyse 7- 
hydroxycoumann in serum or urine without extraction due to the endogenous 
species present in the matrix which absorb at 210 nm and interfere with the 
detection of 7-hydroxycoumann present [11]
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A 0 1 ml volume of 7-hydroxycoumann standard and 0 9 ml of control urine 
or serum was added into a 10 ml sterile blood tube (Medlabs, Dublin, 
Ireland), giving a senes of calibration standards from 0 to 50 ¿ig/ml A 1 ml 
volume of a unne sample from a volunteer was also added mto a 10 ml tube 
for analysis The internal standard (0 05 ml) was added to both standards and 
unknowns and vortex mixed for 20 seconds Diethyl ether (3 5 ml) was then 
added to each tube to extract the 7-hydroxycoumann and internal standard 
The tubes were mixed by rotation for 10 minutes and centn&ged at 600 g  for 
10 minutes A 1 8 ml volume of the diethyl ether layer was removed mto a 75 
x 12 mm glass tube (M S C , Dublin, Ireland) and evaporated to dryness at 60 
°C The sample was reconstituted mto 0 1 ml of 0 025 M phosphate buffer 
(pH 7 5) Samples were not filtered before injection Smce 7- 
hydroxycoumann is found predominantly m the 7-hydroxycoumann- 
glucuromde form m unne, it must be treated with |3-glucuromdase to liberate it 
to the free (non-conjugated) form for analysis Therefore, the unne was 
treated with 1 ml of P-glucuromdase (Sigma) at 5000 umts/ml in 1 M sodium 
acetate (Sigma) buffer, pH 5 0 The mixture was gently mixed and mcubated 
at 37 °C for 30 min There was no internal standard used m the determination 
of total 7-hydroxycoumann The sample was then analysed on a Beckman 
Capillary Electrophoresis instrument (P/ACE System 2050)
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2 2 3 CAPILLARY ELECTROPHORESIS SEPARATION
The capillary used was a 27 cm x 50 |im ID  fused silica column (Beckman 
Instruments), with a capillary to detector distance of 19 3 cm The 
preparation step for priming of the capillary was a 1 mm rinse wife 0 1 M 
sodium hydroxide, and then a 1 nun nnse with electrolyte solution (0 025 M 
phosphate buffer, pH 7 5) The sample was applied to the capillary by a 3 
second pressurized injection (0 5 p s i )  and separation achieved with an 
applied voltage of 20 kV (rise time 0 2 min) at 25 °C Typical running 
current was 100 jaA The resultant electropherogram was monitored at 210 
nm with a fixed wavelength detector using Beckman System Gold software 
Migration times for all components varied within ± 0 1  mm due to slight 
differences in operating conditions e g capillaiy conditioning The precision 
of migration time values could perhaps be improved by longer conditioning of 
the capillary with electrolyte solution Concentrations for total and free 7- 
hydroxycoumann m the volunteer's unne was calculated from the respective 
standard curves prepared
For the analysis of free 7-hydroxycoumann, plots of absorbance ratio Versus 
concentration (fxg/ml) were made Absoibance ratios for the analysis of free 
7-hydroxycoumann were calculated from the equation (absorbance of 7- 
hydroxycoumann / absorbance of internal standard), and for total 7- 
hydroxycoumann the concentration was calculated from a plot of 7- 
hydroxycoumann absorbance versus standard concentration (|xg/ml) Inter­
assay and intra-assay vanation m absorbances, and absorbance ratios were 
assessed (n=5 (free), n=6 (total)) by analysing calibration standards and 
calculating the mean absorbances and absorbance ratios and their related
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standard deviations Percentage relative standard deviations were also 
calculated
2.3 RESULTS AND DISCUSSION
2 3 1 DEVELOPMENT OF THE CE SEPARATION
Various buffers were first investigated in an attempt to separate coumann and 
7-OHC Although several of the buffers showed some separation, phosphate 
buffer was chosen, as it gave nse to the best resolution between coumann and 
7-hydroxycoumann The pH of the phosphate buffer electrolyte (using 25 
mM) was then investigated between pH 5 6 and pH 7 5, and the best 
separation between coumann and 7-OHC was achieved at pH 7 5 (Fig 2 3) 
The ionic strength of the buffer was then assessed At 0 1 M, a veiy high 
running current was exhibited, but use of 0 025 M phosphate buffer 
concentration was found to decrease the current to 100 jjA  In the analysis of 
free 7-hydroxycoumann, an internal standard, 3-(a-acetonylbenzyl)-4- 
hydroxycoumann, was utilised However, the internal standard was not used 
in the determination of total 7-hydroxycoumann
A CE separation of a mixture of coumann, 7-hydroxycoumann and the 
internal standard is shown in Figure 2 4 From this it can be seen that the 
three compounds are well separated with baseline resolution within 1 2 
minutes Coumann has a net zero charge at pH 7 5 and migrates with the 
solvent front, i e at the same migration time as a neutral marker, benzamide
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This means that the method described above cannot be used for the 
quantification of coumann in biological fluids
pH
Fig 2 3 Plot showing separation of coumann and 7-OHC between pH 5 6 
and pH 7 5 in 25 mM phosphate buffer electrolyte
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Time (min)
Fig 2 4 Capillary electrophoresis separation of (A) coumann, (B) 7-OHC, (C) 
contaminant of 7-OHC standard, and (D) internal standard They were 
prepared in 0 025M phosphate buffer, pH 7 5 and analysis was earned out as 
in Experimental
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At the pH chosen, the separation of coumann from 7-hydroxycoumann is 
achieved by virtue of the charge difference between the two compounds (7- 
hydroxycoumann is partially negatively charged at pH 7 5) The separation 
was then applied to the analysis of unne and serum samples as outlined under 
the Experimental section The separation of the compounds in the unne 
extract is shown in Figure 2 5, where it can be seen that there are only 
minimal interference’s to the analysis of 7-hydroxycoumann from co­
extracted endogenous species in the unne The CE analysis of total 7- 
hydroxycoumann in a unne sample taken from a volunteer 6 hours after 
administration of coumann is shown in Figure 2 6 It indicates that most of 
the mterferents have longer migration times compared with those of the drug 
and its metabolite This figure also shows that the internal standard cannot be 
used in the analysis of total 7-hydroxycoumann owing to the greater number 
of mterferents occurring at its migration time There was also irreproducible 
extraction of the internal standard after the treatment of the unne sample with 
p-glucuromdase Efforts to find a alternative internal standard which would 
elute later m the electropherogram and extract reproducibly, proved fruitless
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Time (min)
Fig 2 5 Electropherograms of blank unne and 50 ng/ml 7- 
hydroxyconmann standard and internal standard prepared in unne (A) solvent 
front, (B) 7-hydroxycoumann, (D) internal standard and (E) co-extracted 
endogenous species The samples were prepared and analysed as outlined in 
Experimental The figure shows an overlay of the two electropherograms
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\Time (min)
Fig 2 6 CE analysis of total 7-hydroxycoumann in a urine sample from 
volunteer 2, 6 hours after administration of coumann (A) Solvent front 
containing any compounds which would be liberated by the addition of p- 
glucuromdase, thus explaining the increase in absorbance at the solvent front 
as compared to untreated urine, (B) 7-hydroxycoumann and (E) co-extracted 
endogenous species in unne
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The CE analysis of a serum extract is shown in Figure 2 7 From this it can be 
seen that there is good separation between the metabolite, the internal 
standard and the majority of the co-extracted interfering substances
The method was then compared to the previously developed HPLC method 
[22] for the quantification of 7-hydroxycoumann in the urine of volunteers 
who had been administered coumann Tables 2 1 and 2 2 compare the results 
obtained from each of the methods Figure 2 8 shows the comparison of CE 
analysis versus HPLC analysis of total 7-OHC excretion for volunteer 2 This 
plot shows that the two methods of analysis give the same profile for 
excretion of 7-OHC by a given volunteer When, however, one compares the 
run times for the samples, one immediately realises the diminution in the time 
for the determination step (at least eight fold) between the two techniques 
The method also has a fast regeneration step to recondition the capillary 
column between every analysis There are no carryover problems, less 
solvents are used, and there is minimal organic solvent waste as compared 
with the reversed-phase HPLC method To improve the sensitivity of the 
method, 324 am could be used as the detection wavelength, as in the HPLC 
[22] method However, as with the HPLC method, a clean-up procedure is 
needed for the biological samples pnor to analysis [11]
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Time (min)
Fig 2 7 Electropherograms of blank serum and 50 jug/ml 7- 
hydroxycoumann standard and internal standard in serum (A) Solvent front,
(B) 7-hydroxycoumann, (C) contaminant in standard, (D) internal standard, 
and (E) co-extracted endogenous species in serum
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7-OHC concentration (fig / ml)
Volunteer 1 Volunteer 2
Time
(hr)
Free
(CE)
Total
(CE)
Total
(HPLC)
Free
(CE)
Total
(CE)
Total
(HPLC)
0 1 4 0 0 0 0 0 0 1 0 1 2
2 5 9 429 0 479  0 9 0 735 0 759 0
6 0 0 77 2 73 3 0 0 42 7 35 6
10 1 0 25 8 23 6 0 0 3 8 4 0
14 1 7 11 3 9 3 0 0 0 0 0 0
24 0 0 0 0 1 0 0 0 0 0 1 0
Table 2 1 Comparison of HPLC and CE analysis of unnary concentration 
of 7-OHC excreted over 24 hours following oral administration of 100 mg of 
conmann
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7-OHC excreted (mg)
Volunteer 1 Volunteer 2
Tune (hr) CE HPLC CE HPLC
0 00 00 0 50 06
2 64 35 71 85 73 50 75 90
6 23 16 21 99 25 62 21 36
10 3 61 3 30 2 09 2 20
14 1 13 0 93 00 00
24 00 0 30 00 04
Total 92 25 98 37 10171 10046
Coumann
excreted*(%)
83 1 88 7 917 90 5
* % Coumann excreted calculated from molecular mass ratios (0 9012), 1 e 
(mol wt coumann) / (mol wt 7-OHC)
Table 2 2 Companson of HPLC and CE analysis for determination of the 
amount of 7 -hydroxycoumann, m milligrams, excreted and % coumann 
excreted over a 24 hour penod
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Fig 2 8 Plot of CE analysis versus HPLC analysis of total 7-OHC excreted 
over 24 hours for volunteer 2
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2 3 2  LIMIT OF QUANTIFICATION AND LINEARITY
In both unne and serum the limit of quantification of 7 -hydroxycoumann was 
found to approximately 1 0 jig/ml and the linear detection range for the 
analysis of the drug was from 1 to 50 jig/ml Correlation coefficients were 
always better than 0 990
23 3 ACCURACY AND PRECISION
Inter- and intra- assays for the determination of 7-hydroxycoumann were 
earned out and the respective mean absorbances and mean absorbance ratios, 
and standard deviations calculated (Tables 2 3 and 2 4) The percentage 
relative standard deviation was found to be within 0 8% to 7 3% The mter- 
assay accuracy and precision for free 7-hydroxycoumann was determined 
over a five day penod The intra-assay accuracy and precision for free drug 
was determined over five calibration sets on one specific day The inter-assay 
analysis for total drug was determined over six days The use of the internal 
standard was not of significant benefit for the determination of free 7- 
hydroxycoumarm
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Concentration
(Hg/ml)
Absorbance 
ratio 
(mean ± S D.) 
Free 7-OHC
RS.D.
(%)
Absorbance 
(mean ± S.D.) 
Total 7-OHC
RS.D
(%>
0 00 00 00 0 0
1 4 0E-2±2 8E-3 70 2 35E-3+1 59E-4 68
5 0 1541±1 13E-2 73 8 58E-3±5 30E-4 62
10 02951±9 90E-3 34 1 70E-219 25E-4 54
20 0 5812±2 20E-2 38 3 09E-2+1 68E-3 54
50 1 278±3 63E-2 28 7 13E-2+3 25E-3 46
Table 2 3 Inter-assay precision and accuracy for free and total 7- 
hydroxycoumann analysis following extraction from urine (free n = 5, total n
= 6)
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Concentration 
(Mg /ml)
Absorbance ratio 
(mean ± S D )
R SD
(%)
0 0 00
1 3 52E-2+1 90E-3 54
5 0 1509±7 20E-3 48
10 0 2809±6 36E-3 23
20 0 5221±2 35E-2 45
50 1 1750±8 90E-3 08
Table 2 4 Intra-assay precision and accuracy for free 7-hydroxycoumann 
analysis following extraction from urine (n=5)
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2 3 4  CLINICAL AND PHARMACOKINETIC STUDIES
The method developed above was applied to urine samples obtained from two 
volunteers who had been administered coumann Their urine was analysed 
for free and total 7-hydroxycoumann During the analysis no free or 
conjugated coumann was observed in the volunteer's unne (this was 
determined from HPLC analysis) All of the coumann appears in either of the 
7-hydroxylated forms The concentrations of free and total 7- 
hydroxycoumann present were calculated from standard curves prepared on 
the day of analysis and fee results obtained were related to fee urinary 
volumes excreted giving the total amount of 7-hydroxycoumann excreted in 
milligrams Percentage of administered coumann, excreted as 7- 
hydroxycoumann was then calculated from molecular weight ratios (Table 
2 2)
The results showed that up to 70 % of the coumann is excreted in the first two 
hours and feat approximately 90 % is excreted within 24 hours These results 
are in accordance with those of Egan et al [22] and Rautio et al [23] In fee 
companson of the results from CE and HPLC analysis of fee volunteer’s unne 
samples there was no statistical difference (Tables 2 1 and 2 2)
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2.4 CONCLUSION
The use of capillary electrophoresis for the determination of 7- 
hydroxycoumann in urine and serum was found to be straight forward and 
reliable, and in comparison to more established methods (e g HPLC), the 
separation step was much more rapid To determine concentrations of 7- 
hydroxycoumann in a pharmacokinetic study or clinical tnal [24], where the 
coumann dosage is from 100 mg upwards, the use of CE would be ideal due 
to the availability of autosamplers and the speed at which the data is obtained 
Thus the analysis of multiple samples can be made faster The total 
preparation time of the samples does not vary from the other methods 
available [22], but the analysis time is greatly decreased To analyse 7- 
hydroxycoumann at lower concentrations, other detection methods could be 
utilised [25,26] The availability of photodiode array detectors, computer 
controlled systems, the minimal solvent waste involved, and the ease of 
method development makes CE a very useful and rapid analytical tool m the 
analysis of biological samples
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CHAPTER 3
STUDY OF COUMARIN METABOLISM BY LIVER 
MICROSOMES USING CAPILLARY ELECTROPHORESIS 
AND ELECTROCHEMISTRY
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3.1 INTRODUCTION
The metabolism of coumarui or any compound m the human body can be 
described by the general reaction shown below
P450
NADPH + fT + 0 2 + XH --------- > NADP+ + H20  + XOH
where P450 is a cytochrome P450 enzyme and XOH is a metabolite which 
m the case of coumann is mainly 7-OHC (m humans) NADPH 
(nicotinamide adenine dinucleotide phosphate) is needed to donate two 
electrons to the heme iron of cytochrome P450 [1] The above reaction is 
referred to as a monooxygenation and the enzyme as a monooxygenase 
because only one of the two oxygen atoms is incorporated mto the 
substrate Microsomal preparations from hver contain cytochrome P450 
isoforms and have been used to study the metabolic pathways of drugs [2-
5]
The cytochrome P450’s are a family of heme protems present in all 
mammalian cell types, with the exception of mature red blood cells and 
skeletal muscle cells These enzymes catalyse the oxidation of a wide 
variety of structurally diverse compounds Substrates for these enzyme 
systems mclude endogenously synthesised compounds such as steroids, 
and compounds such as drugs, food additives or industrial by products that 
enter the body through food sources, ingestion, inhalation from the air or 
absorption through the skin The cytochrome P450 has many effects in 
medicine It has roles in (a) inactivation or activation of therapeutic
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agents, (b) metabolism of chemicals to highly reactive molecules, which 
may produce unwanted cellular damage, cell death or mutations, (c) 
participation in several steps m steroid hormone biosynthesis, and (d) 
metabolism of fatty acids and then derivatives [1]
3 1 1 NOMENCLATURE
The original designation of a protem as cytochrome P450 originated from 
its spectral properties The cytochrome P450 enzymes have a unique 
absorbance spectrum which is obtained by adding a reducmg agent (e g 
sodium dithiomte), to a suspension of endoplasmic reticulum vesicles 
(microsomes), this is followed by the addition (through bubbling) of 
carbon monoxide gas into the solution The carbon monoxide becomes 
bound to the reduced heme protem and this produces an absorbance 
spectrum with a peak at 450 tun Specific forms of cytochrome P450 can 
differ m their maximum absorbance wavelength, and the range vanes 
between 446 and 452 tun [1]
It is clear that m mammalian cells, cytochrome P450’s serve as terminal 
electron acceptors and monooxygenases in electron transport systems, 
which are contained either m the endoplasmic reticulum or the inner 
mitochondnal membrane The cytochrome P450 structure has present a 
single non group, and the resulting heme protem has binding sites for both 
an oxygen molecule and the particular substrate The heme iron of all 
known cytochrome P450’s is bound to the four pyrrole nitrogen atoms of 
the porphyrin ring and two axial ligands The heme non can exist m two
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different spin states (1) a hexa-coordinated low spin iron, or (2) penta- 
coordinated high-spm state The low and high spin states are descriptions 
of the electronic shells around the iron atom When a substrate binds to 
cytochrome P450, there is a change m these electronic shells and the heme 
iron atom changes from the hexa-coordinated to the penta-coordinated 
state The substrate bound, penta-coordinated state has a more positive 
reduction potential than the hexa-coordinated unbound state This 
accelerates the rate at which cytochrome P450 may be reduced by 
electrons donated from NADPH (Fig 3 1) In order for the hydroxylation 
(monooxygenation) reaction to occur, the heme iron must be reduced from 
the Fe(ni) to the Fe(Ef) state, so that oxygen may bind to the heme iron 
A total of two electrons are required for the monooxygenation reaction [1]
Fig 3 1 The sequence of reactions at cytochrome P450 The diagram 
demonstrates the binding of substrate, transfer of the first and second 
electrons, and binding of molecular oxygen Reproduced from Ref [1]
i \ O,
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3 1 2 SPECIFICITY
It has been known since the mid-1950’s that it is possible to insert one of 
the atoms of molecular 0 2 into a substrate being metabolised This process 
of monooxygenation is also performed by other specialised protems such 
as hydroxylases but none of these protems display the versatility of the 
members of the cytochrome P450 family It is now clear that many forms 
of cytochromes P450 have emerged due to gene duplication events 
occurring m the last 5-50 million years The different forms of cytochrome 
P450, which are now known among the various animal species, have most 
likely arisen from the selective pressure of environmental influences, such 
as dietary habits or exposure to environmental agents [1]
By 1990, over 150 cytochrome P450 genes, coding for different protems 
catalysing the oxidation of a variety of endogenous substrates had been 
characterised One of the ways of characterising these enzymes is by 
substrate specificity While this has been possible with many of the 
members of this family, the similarity of molecular weights and other 
molecular properties has made purification of individual cytochrome 
P450’s from the same organ very difficult
The induction of various cytochromes P450 by both endogenous and 
exogenous compounds has been known since the mid 1960’s The 
mechanism of the mduction of cytochrome P450 has been demonstrated to 
be at the transcriptional or post-transcnptional level and it is not possible 
to predict the mode of mduction based on the inducing compound For 
some time it was thought that understanding the control of the intracellular
73
level of a protein was primarily a question of knowing what controlled the 
synthesis of that protein îe  a question of genetic regulation More 
recently, it has been learned that intracellular protein degradation is also 
important m determining the enzyme level Clearly the intracellular 
concentration of an enzyme molecule is determined by both its rate of 
synthesis and its rate of degradation [6]
3 1 3 CYTOCHROME P450 ELECTRON TRANSPORT SYSTEMS
It is well known that the cytochrome P450-catalysed reaction requires 2e' 
to accomplish its task of heme iron reduction, oxygen binding and oxygen 
cleavage, but a basic mechanistic problem is the direct and simultaneous 
transfer of electrons from NADPH to cytochrome P450 Pyridine 
nucleotides are 2e' donors, but cytochrome P450, with its single heme 
prosthetic group, may only accept le ' at a tune As a result of this, a 
protem that serves to transfer electrons from NADPH to the cytochrome 
P450 molecule must have the capacity to accept 2e‘ but operate as a le ' 
donor This problem is overcome by the presence of a NADPH-dependent 
flavoprotem reductase, which accepts 2e' from NADPH simultaneously, 
but transfers the electrons individually to cytochrome P450 The transfer of 
electrons from NADPH to cytochrome P450 is accomplished by two 
distinct electron transport systems that reside almost exclusively m either 
mitochondria or endoplasmic reticulum [1]
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NADPH donates electrons to a flavoprotein called NADPH-cytochrome 
P450 reductase, in the endoplasmic reticulum This reductase has a mass 
of approximately 78,000 and contains both flavin adenine dinucleotide 
(FAD) and flavin mononucleotide (FMN) as prosthetic groups A 
significant number of residues at the ammo end of the molecule are 
hydrophobic, and this portion of the molecule is embedded in the 
endoplasmic reticulum (Fig 3 2)
Fig 3 2 The sequence of reactions at cytochrome P450 The diagram 
demonstrates the binding of substrate, transfer of the first and second 
electrons, and binding of molecular oxygen. Reproduced from Ref [1]
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The FAD serves as the entry point for electrons from NADPH, and FMN 
serves as the exit point, transferring electrons individually to cytochrome 
P450 Because the flavin molecule may exist as 1 or 2e' reduced forms and 
two flavin molecules are bound per reductase molecule, the enzyme may 
receive electrons from NADPH and store them between the two flavin 
molecules before transferring them individually to the heme iron for 
oxygen binding (first electron) and cleavage of the oxygen molecule 
(second electron), see Fig 3 1
3 1 4 PREVIOUS WORK ON COUMARIN METABOLISM USING
LIVER MICROSOMES
Fentem and Fry [7-10] have done significant work on monitoring coumann 
metabolism m hver microsomes Most of this work has been done with the 
aid of HPIC In 1990, Fentem et al [7] reported on the effect of various 
mducers of cytochrome P450 on the metabolism of coumann by rat hver 
microsomes Liver microsomes were prepared from rats given sodium 
phenobarbitone, P-naphthoflavone, isoniazid or pregnenolone-16-alpha 
carbomtnle The incubation mixture contained the microsomes, phosphate 
buffer, MgS04, NADP+, glucose-6-phosphate, glucose-6-phosphate 
dehydrogenase and coumann The mixture was then incubated for 10 
minutes followed by the addition of trichloroacetic acid (TCA) to stop the 
reaction, the TCA had the effect of precipitating out protein The 
precipitated protein was then removed by centnfugation, and the 
supernatant assayed by HPLC The HPLC system consisted of a 
Sphensorb 5 ODS-2 column, UV detection at 280 nm and a flow rate of 2
76
ml/min, with the column bemg maintained at 40°C Gradient elution was 
used for the separation with mobile phase A = formic acid/water (5 95) 
and B = methanol The gradient program was 2 stage, 0-2 mm, 10-20% B, 
2-25 mm, 20-65% B This produced a good separation of coymann from 
10 of its reported metabolites One of the major drawbacks of the HPLC 
method was that the protem from the incubation mixture had to be 
removed prior to injection onto the HPLC system This is a common 
problem with standard reversed-phase columns as the protem would 
rapidly degrade the column
Fentem and Fry [8] again used this HPLC method to study the effect of 
cimetidme on the metabohsm of coumann by rat, gerbil and human liver 
microsomes Fentem et al [9] also reported on a novel metabohte of 
coumann (o-hydroxyphenylacetaldehyde) formed by rat, gerbil and human 
liver microsomes The above HPLC method was used to follow 
metabohsm along with isolating and partially punfymg the new metabohte 
by collecting appropnate fractions of the column eluent The new 
metabohte was identified by mass-spectral data
Metabolism of coumann by rat, gerbil and human liver microsomes was 
then reported by Fentem and Fry in 1992 [10] This above HPLC method 
was central to the analysis of the metabolites This publication shows the 
separations achieved after the incubations (the protem had been 
precipitated out by TCA and centnfugation) The separation, however, 
exhibited a poor baseline (even after protem precipitation), underlining the 
problems which can be encountered when trying to separate components 
of biological reactions The matnx can be extremely complex, leading to 
problems m achieving a good baseline throughout a separation
77
Lake et al [11-17] have also done a lot of work on monitoring coumann 
metabolism m liver microsomes In 1980, Walters et al [11] reported on 
their investigations which were undertaken m order to develop a HPLC 
procedure capable of resolving and quantitating the known metabolites of 
coumann which would be applicable to the determination of metabolites in 
biological samples and tissue mcubates A number of different stationary 
phases were evaluated in this work, with the best results being achieved 
with a Partisil-10 ODS-2 column, along with a two stage linear gradient 
Reservoir A contained THF water acetic acid (10 900 1), reservoir B 
contained THF water acetic acid (20 80 0 1) Elution was with 46% B for 
16 nun followed by a linear mcrease of 1% per nun in B up to 62% B (i e 
over 16 mm) This was held for 8 nun, then 5% mcrease m B up to 100% 
B This method was able to separate O-HPLA, 8-OHC, 6-OHC, 7-OHC, 
C, 5-OHC, 3-OHC, 4-OHC and o-coumanc acid Difficulty was 
encountered when working with real biological samples and 
ultracentnfugation of incubation mixtures was needed 
The effect of inducers of cytochrome P450 on the metabohsm of [3- 
14C]coumarm by rat hepatic microsomes was reported by Peters et al [12] 
m 1991 Metabolic studies on radio-labelled coumann were earned out 
using HPLC as the analytical tool The metabolites were separated by 
using reversed-phase liquid chromatography employing a Partisil 10 ODS- 
2 column and a mobile phase containing 25% THF m water (A), water (B) 
and 1% (w/w) formic acid m water (C) Elution was achieved by starting 
with 22% A 58% B 20% C and after 20 minutes changing to 36% A 
44% B 20% C using a concave gradient over 15 minutes and then to 80% 
A 0% B . 20% C over 7 minutes and held for a further 30 minutes before 
re-equihbration of the column The eluent was momtored at 273 nm
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The metabolism of [3-14C]coumarm to polar and covalently bound 
products by hepatic microsomes from the rat, hamster, gerbil and human 
was reported on by Lake et al [13] m 1992 The metabolism of the radio- 
labelled coumann was studied by HPLC, with the metabolites being 
determined by comparison with retention times of known standards and 
the concentrations being quantified by measurement of the radioactivity 
present m the appropriate HPLC fractions Incubations were terminated 
with ice cold methanol, followed by centrifugation prior to injection onto 
the HPLC system The HPLC system (same as was used m [12] above) 
could separate coumann and 13 of its metabohtes, but it suffered from the 
necessity to centrifuge the samples pnor to analysis 
Lake et al [14] also used this method to identify o- 
hydroxyphenylacetaldehyde as a major metabolite of coumann in rat 
hepatic microsomes The metabolism of [3-14C]coumann by human liver 
microsomes was then studied m 1994 by Van Iersel et al [15] using this 
HPLC method and Steensma et al [16] also used it to study the 
metabohsm of coumann and 7-ethoxycoumann by rat, mouse, guinea pig, 
monkey and human hver slices Very recently Lake et al [17] again used 
the method to study the metabohsm of coumann by calf hver microsomes
HPLC was also used by Goeger and Anderson [18] m the biochemical 
charactensation of coumann 7-hydroxylase activity m chick embryo hver 
microsomes After incubation, the reactions were terminated by the 
addition of methanol followed by centnfugation The HPLC system 
consisted of a fxBondapak Cig column with an isocratic mobile phase of 
methanol-water-acetic acid, at a flow of 2 ml/nun The 7-OHC produced 
was monitored using a fluorescence detector
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Other methods have also been used to study the metabolism of coumann 
by liver microsomes In 1980, Legrum and Netter [19] used gas 
chromatography-mass spectroscopy (GC-MS) to study the characteristics 
of coumann metabolism by liver microsomes from cobalt-pretreated mice 
Reactions were stopped by the addition of TCA followed by centifugation 
and the supernatant was extracted with diethyl ether Denvatisation was by 
methylation, which was earned out by passmg diazomethane mto the 
extract Isolation of the metabolites was by TLC followed by GC-MS
The purpose of this present study was to develop a capdlary 
electrophoresis method to study the metabolism of coumann without any 
sample preparation The separations are also earned out m much shorter 
times The following sections will desenbe how the separation was 
developed, optimised and applied to metabolic studies usmg human liver 
microsomes, with a separate study on interspecies differences m coumann 
metabolism Electrochemical methods were also used m an effort to follow 
the metabolism of coumann
8 0
3.2 A STUDY OF COUMARIN METABOLISM BY CAPILLARY
ELECTROPHORESIS
32  1 EXPERIMENTAL 
3 2 11 Chemicals
7-hydroxycoumann, NADPH, NADP+, D-glucose-6 -phosphate and 
glucose-6 -phosphate dehydrogenase were purchased from Sigma (St 
Louis, MO) KH2P04 and K2HPO4 were obtained from Riedel-de Haen 
(Hanover) 7-OHC standards were prepared from a 1 mg/ml stock m 
methanol (HPLC grade, Labscan, Dublin) deiomsed water (10 90, v/v) by 
dilution m deiomsed water The electrolyte solution used when monitoring 
metabolite formation was 0 025 M phosphate buffer, pH 7 0 The pH was 
adjusted to pH 7 5 when monitoring NADPH and NADP+ migration The 
electrolyte was prepared daily by dissolving 0 02 M K2HPO4 and 0 005M 
KH2PO4 m deiomsed water Coumann (2  05 x lO^M m 0  1 % methanol 
99 9% ultra pure water) was donated by Schaper and Brummer 
For the mterspecies investigations the electrolyte used was 50 mM 
phosphate btiffer, pH 6 8
3 2  12 Tissue preparation
The five donors of human microsomes were patients either with carcinoma 
of the colon or small intestine and a single liver metastasis, or patients with 
primary liver tumours, who all underwent partial hepatectomy Portions of 
macroscopically healthy liver, taken from the excised lob, were chilled 
immediately m 1 15% KC1 (0°C) and were then frozen m liquid nitrogen
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within a few minutes. Microsomes were obtained by differential 
centrifugation using the sucrose method [20], The characteristics of the 
donors are summarised in Table 3.1. The protein concentrations of these 
microsome preparations were calculated using the bicinchoninic acid 
(BCA) assay (Pierce).
Table 3.1 Details of liver donors
Liver Donor sex Donor age (years) Smoking status
P13 F 64 NS
P14 F 48 NS
P17 F 54 S
P18 F 44 NS
R1 M 54 NS
For the interspecies investigations, a kit of microsomes of different species 
(beagle dog, cynomolgus monkey, New Zealand white rabbit, female rat 
SD-OFA) was purchased from IFFA Credo, L’Arbresle Cedex, France. 
Values for protein concentrations in the microsomal preparations were 
included for each species. Livers from other species (gerbil, mouse, 
(Schofield, CD1), bovine, porcine) were obtained from freshly sacrificed 
animals. Microsomal preparations form these species were prepared by the
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sucrose method of Wolff et al [19] Protein concentrations were 
determined by the Bicmchommc Acid (BCA) Assay (Pierce, Illinois, 
USA)
3 2 13 Bicmchommc Acid (BCA) Protein Assay
The protem concentration of the microsomes were determined by this 
assay method In this assay Cu(II) combines with protem, under alkaline 
conditions to form Cu(I), which reacts with BCA to give a coloured 
product Protem was detected quantitatively usmg BCA (Pierce) Two 
separate reagents are supplied reagent A, an alkaline bicarbonate buffer, 
and reagent B, 4 % (w/v) copper(II) sulphate solution The working 
solution required the addition of 50 parts of reagent A to 1 part of reagent 
B A range of protem standards (0-1 mg/ml) were prepared i n O l M  PBS, 
pH 7 4 10 |j.l of standard or sample was added to 190 p.1 of working 
solution m a well of a 96 well microtitre plate For control wells, 10 jj! of 
diluent was used The plate was mcubated at 37°C for 30 nun The 
absorbance was recorded at 562 nm on a Titretek Twinplus reader All 
samples and standards were prepared m duplicate The protem 
concentration of the unknown samples were determined from a standard 
curve
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3 2 14  Incubation solution
The concentrations of the NADPH-generatmg system in all human liver 
microsome incubations was 4U/ml glucose-6-phosphate dehydrogenase, 2 
mg/ml D-glucose-6-phosphate, and 1 2 mM NADP+ This was higher than 
that required to maintain maximum metabolite rates under the chosen in 
vitro conditions The coumann (substrate) concentration in the incubation 
solutions was always 1 6 x lO^M
For the incubations 195 jal of a coumann standard (30 jj,g/ml, prepared in 
phosphate buffer, pH 7 5, 25 mM), 10 jul of D-glucose-6-phosphate (50 
mg/ml), 15 (il of NADP+ (20 mM) and 5|ul of glucose-6-phosphate 
dehydrogenase were mixed together m an eppendorf tube to give final 
concentrations as above As can be seen, the reaction was earned out in 
phosphate buffer, pH 7 5, as this is the optimum pH for the P450 reaction
[2] The reaction was started by the addition of 25 jul of microsomal 
suspension (the microsomal preparations were called P13, P14, P17, P18 
and R l), resulting in a final protem concentration of about 2 mg/ml 
Following mixing, the open eppendorf tube was transferred immediately 
into the incubation bath (37°C), and a 20 (il sample taken and analysed 
The metabolite formation was monitored over a two hour penod, taking 
samples at 0, 7, 14, 20, 30, 45, 60, 90 and 120 minutes, respectively 
These samples were analysed using a Beckman capillary electrophoresis 
instrument (P/ACE System 2050) In the case of analysis by LC, the 
incubation was first stopped by the addition of 50 jj.1 of ice-cold 
trochloroacetic acid (20% w/v) and centnfuged (low speed) before 
injection The LC analysis was earned out according to the HPLC method 
of Egan and O’Kennedy [21] The HPLC system used was a reversed-
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phase chromatographic system, with a degassed mobile phase of methanol- 
water-acetic acid (30:70:0.2). The column used was a Waters C\% 
nBondapak (30 cm x 3.9 mm i.d.) at ambient temperature, with a 10 jam 
particle size. The flow rate was 2 ml/min and the wavelength of detection 
was 324 nm. Quantitation of 7-OHC was performed by measuring peak 
heights relative to a standard curve.
The incubation solution for the interspecies investigations was very similar 
to that used above for the human liver microsome work. The incubation 
solution consisted of 195 jj.1 of 30 jig/ml coumarin, 10 fxl of 50 mg/ml 
glucose-6-phosphate, 5 nl of 200 units/ml glucose-6-phosphate 
dehydrogenase, 15 j j.1 of 20 mM NADP+ and 25 jj.1 of the microsomal 
preparation. For these investigations, the incubations were carried out in
1.5 ml eppendorf tubes at 37°C. The reaction was again commenced with 
the addition of the microsomes. 10 (j.1 samples were taken and analysed 
immediately with minimal time delay between sampling and analysis. The 
concentration of 7-OHC was determined at predefined times i.e. 1, 6, 12, 
20, 30,45, 60, 90 and 120 minutes, respectively. The analysis was carried 
out in triplicate.
3.2.1.5 NADP+/NADPH ratio study
For this study, the concentration of glucose-6-phosphate dehydrogenase 
was reduced to 0.1 U/ml to allow a slower turn-over of NADP+ to 
NADPH. The remainder of the incubation mixture was as above. The
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study was earned out in the presence and in the absence of coumann, or 
the microsomal preparation
3 2 16 Capillary electrophoresis separation
Separations were earned out on a Beckman Capillary Electrophoresis 
instrument (P/ACE system 2050) The capillary used was a 27 cm x 50 jam 
fused silica column (Beckman), with a capillary to detector distance of 
19 3 cm The preparation step for priming of the capillary was a 1 minute 
rinse with 0 1 M sodium hydroxide, followed by a 1 minute rinse with 
electrolyte solution (25 mM phosphate buffer, pH 7 0 or 7 5, depending on 
the separation required) The sample was apphed to the capillary by a 3 
second pressunsed injection (0 5 p s l) and separation achieved with an 
apphed voltage of 20 KV (nse tune 0 2 minutes) at 25 °C Typical running 
current was 100 |xA The resultant separation was monitored at 210 nm 
with a fixed wavelength detector usmg Beckman System Gold™ software 
For the interspecies investigational work, the same capillary was used as 
above This time the capillary was purged for 0 75 minutes with 0 1M 
sodium hydroxide Conditioning of the capillary was then achieved by a 1 
nun rinse with the 50 mM phosphate buffer electrolyte solution The 
sample was again apphed by a three second pressunsed injection (0 5 
p s i ) and the separation was earned out at 15 KV (nse tune 0 2 minutes) 
at 25°C, with UV detection at 214 nm
8 6
3.2.2 RESULTS AND DISCUSSION
3.2.2.1 Overall reaction in the incubation solutions
The overall reactions in the incubation solutions are as follows:
GI-6-ph-dehydrogenase
(1) NADP+ + Glucose-6-phosphate---------- > NADPH + Ribose-6-phosphate
P450
(2) NADPH + i f  + 0 2 + coumarin----------- > NADP+ + H20  + 7-OHC
When the incubation solution reaction is initiated NADP+ is converted to 
NADPH, after which time the P450 can begin to catalyse the reaction 
between the NADPH and coumarin (in the presence of hydrogen and 
oxygen). As the reaction proceeds, NADP+ is produced and it can then 
react again with glucose-6-phosphate, and NADPH is recycled in this way. 
Any chromatographic method to follow this reaction must be able to 
separate coumarin and 7-OHC from the co-factors and interference from 
the microsomal protein absorbances.
3.2.2.2 Development of the CE separation
The CE method developed for monitoring 7-OHC in plasma and urine as 
discussed in chapter 2 was adapted for studying the metabolism of 
coumarin by human liver microsomes. When interested in N AD? and
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NADPH, a pH of 7 5 was required, as these compounds exhibit a poor 
peak shape in pH 7 0 electrolyte (phosphate buffer, 25 mM) The 
absorbance of coumann and 7-OHC could be momtored with good 
sensitivity at 210 nm Fig 3 3 shows the separation of coumann and 7- 
OHC (same conditions as m the experimental section above, except using 
15 KV) The electropherogram shows that the compounds can be
separated well by this capillary electrophoresis system
ë* t §tr? so r
ii r,
i
Fig 3 3 Separation of coumann and 7-OHC by the capillary 
electrophoresis system, usmg a 25 mM phosphate buffer electrolyte, pH 
7 5, at 210 nm
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Fig 3 4 shows the typical electropherograms at 0 min and after 45 minutes 
for the metabolic incubation of the PI 8 microsomal preparation This 
figure shows that NADP+ and NADPH are well separated and quantifiable 
at an electrolyte pH of 7 5 The metabolite, 7-OHC, migrates at 1 0 
minutes, and its mcrease m concentration can be followed under the 
conditions outlined m the Experimental section above However, it is not 
well separated from the broad peak of the microsomal preparations at pH 
7 5, and it was found that monitoring at an electrolyte pH of 7 0 (Fig 3 5) 
gave better resolution between the compounds This figure shows how 7- 
OHC can be momtored after 0, 13 and 45 minutes of the incubation A 
number of different phosphate electrolyte pH values between 4 8 and 7 5 
were investigated to optimise the separation, and pH 7 0 produced the 
best results Other electrolyte buffers were also tried, and borate gave 
promising results at pH 7 0, but the background absorbance of the buffer 
was very high, thus decreasing the limit of detection Hepes buffer (pH 
7 0) was also mvestigated, but on mixing with the phosphate buffer from 
the incubations a large dip m the baselme resulted halfway through the run 
It was therefore felt that phosphate buffer would be the most appropriate, 
as the electrolyte, because phosphate buffer was bemg used m the 
incubations and this would alleviate any such problems as seen with Hepes 
buffer above The use of micellular-based electrolyte solution was also 
assessed, but there was no benefit found in utilising such a system for the 
determination of 7-OHC, especially when phosphate buffer is relatively 
simple to prepare
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Fig 3 4 Electropherograms showing separation of (A) all neutral 
compounds including coumann, (B) 7-OHC, (C) microsomes, (D) NADP+ 
, and (E) NADPH, at (i) 0 mmutes and (n) at 45 nunutes monitored at 210 
nm usmg 25 mM phosphate buffer, pH 7 5
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Fig 3 5 Separation of coumann, 7-OHC and microsomes at (a) 0, (b) 13 
and (c) 45 minutes of incubation respectively The incubation solution was 
monitored at 210 nm usmg 25 mM phosphate buffer electrolyte, pH 7 0
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A neutral marker (benzamide) was run under the conditions above, and it 
found to co-migrate with coumann, thus suggestmg that coumann is 
behaving as a neutral molecule at this pH This seems logical when the 
structure is considered
By knowing the migration time of the neutral marker it is possible to say 
that all the compounds that have longer migration tunes than coumann are 
negatively charged and hence migrate more slowly than coumann 7-OHC 
is negatively charged at medium pH values due to dissociation of the 
hydroxyl group at the 7-position The components of the microsomes 
migrate more slowly than the 7-OHC and are seen as a broad peak due to 
the different types of protems m the microsomal suspensions NADP+ has 
a structure with four negative charges and a positively charged nitrogen 
associated with it (Fig 3 6) This leads to an overall charge of 3 negative 
charges This high overall negative charge explains the slower migration of 
NADP+ The NADPH molecule has a similar structure to NADP+, but the 
positive charge on the nitrogen is no longer present (Fig 3 6) As a result, 
this highly negatively charged compound (4 negative charges) has the 
slowest migration rate of all the compounds
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Fig 3 6 Structures of NADP^ and NADPH
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A number of control experiments were earned out to ensure that the 
cytochrome P450 enzymes were responsible for the new compound 
detected at the migration tune of 7-OHC Initially a control incubation was 
earned out which had all the components except the NADPH generatmg 
system No 7-OHC was seen after 130 minutes of incubation, also, the 
coumann peak remained at a constant height through this study A control 
experiment was also earned out which had only microsomes present m the 
incubation to mvestigate if any compounds were produced on mcubatmg 
the P450 enzymes at 37°C No compounds were detected near the 
coumann/7-OHC migration tune region Finally, a control experiment was 
run which all the components in it except coumann In this case, a 
compound was produced m significant amounts which had the same 
migration time as coumann This compound needed the presence of the 
NADPH generatmg system to allow its formation, so it may possibly be 
die product of another enzyme reaction which uses NADPH as its co­
factor The compound formed is likely to be a neutral compound (smce 
coumann is considered neutral relative to the benzamide neutral marker) 
which may suggest that it was not a product of another P450 metabolic 
reaction, as most of these would form relatively polar products As a 
result of the formation of this compound throughout these investigations, it 
was unfortunately not possible to momtor the disappearance of the 
coumann as the reaction proceeded
The conclusion to these control experiments was that only in the presence 
of all of the incubation components (le  NADPH generatmg system, 
coumann, and the microsomes) that 7-OHC was produced, giving nse to 
the new peak around 0 9 min
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3 2 2 3 Coumann metabolism profiles
Concentrations of 7-OHC m the human liver microsomes were calculated 
from the mean of three standard curves prepared by spiking standards of 
7-OHC into three different microsome preparations Fig 3 7 below shows 
the (A) 10 and (B) 20 jig/ml spikes of 7-OHC in the P14 microsome 
preparation
Time(mm )
Fig 3 7 Electropherograms showing the spiking of (a) 10 and (b) 20 jxg/ml 
of 7-OHC mto PI 4 microsome preparation
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The concentration of 7-OHC in the nucrosomes was calculated from a plot 
of absorbance versus standard concentration (ng/ml) A linear calibration 
curve was obtained for 7-OHC between 2-50 jag/ml which passed through 
the origin (see Fig 3 8) The limit of detection (3 x S D background) was 
found to be around 1 |ag/ml
7-OHC concentration (jig/ml)
Fig 3 8 Calibration curve for 7-OHC in the microsomal preparations
%
Linear regression analysis of this data gave an equation
y = a + bx where a = -0 00011
b = 0 0004
R = 0 99931
For the interspecies investigations, standards were prepared by spiking 7- 
OHC standards (2 jd) and microsomes (4 (j.1) into buffer (34 pi) The linear 
range was 2-50 fxg/ml with a lnnit of detection of approximately 1 jxg/ml 
The concentration of 7-OHC produced was calculated from a plot of
absorbance versus concentration of 7-OHC The standard curves were/
prepared m each of the microsomal preparations on the day on which the 
assay was earned out to allow for any day-to-day vanations
The protem concentration of the human liver microsomes was determined 
by the BCA assay as desenbed in the Experimental section above The 
protem concentrations of the different human liver microsomes as 
determined by this method is summansed m Table 3 2
97
Human Liver Microsome Preparation Average Protein Concentration (mg/ml)
n =  2
P13 15 97
P14 15 00
P17 14 42
P18 13 58
R1 18 91
Table 3 2 Protein concentrations of the human liver microsomes
Microsome preparations from five different patients were used in the 
metabolism studies Incubations were earned out m tnphcate Fig 3 9 
shows a plot of concentration of 7-OHC (nmol/ml/mg protem ± S D ), 
versus time for each of the five metabohc studies It shows that each of the 
microsomal preparations has a different coumann metabolism profile, this 
is in agreement with results from many other groups [10,22] In fact, the 
mter-mdividual vanabihty of human coumann 7-hydroxylase activity in 
hver microsomes is very large, and can be up to 70 fold [22] Although the 
errors m concentration calculations are relatively high, the errors 
correspond to errors in microsomal metabolism results from other 
researchers [2] It must be considered that these microsomal preparations 
are extremely complex protem solutions of which total cytochrome P450 is 
less than 1% and 7-hydroxylase bemg but a small fraction of this
98
Time(minutes)
Fig 3 9 Plot of concentration of 7-OHC (nmol/ml/mg protein) + S D 
versus time for five microsome preparations
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Fig 3 10 below shows the comparison of usmg liquid chromatography 
(LC) against capillary electrophoresis for the analysis of the metabolite 
formation It can be seen that there are no significant differences between 
the results from both methods LC is the common method used for this 
analysis of metabolites m cytochrome P450 studies [2-5, 7-17] and also 
for the quantitation of 7-OHC The LC methods involve stoppmg the 
enzyme reactions by precipitating out the protem, followed by 
centrifugation to minimise degradation of the HPLC system The protem 
would have a negative effect both on the HPLC column and also the 
detector cell The cell can become coated with protem and this can effect 
both its sensitivity and the system’s ability to run gradients with relatively 
flat baselmes (a dirty detector cell can give rise to an interfering 
absorbance in gradient runs) The column would also have a shortened life 
if protem solution are allowed to pass through them as the protem can 
become coated on the Qg packing material The column frits could also 
become blocked, resulting in high back pressures, which is generally 
detrimental to pump performance
It was not necessary to precipitate out the protem m the CE method used 
as it mvolved injecting the incubation mixture directly onto the capillary 
This saves a lot of tune m sample preparation and is the mam advantage of 
the method The reaction is stopped by the separation of the individual 
components m the capillary in a very short time, and once separated, they 
are no longer m contact with each other and able to react Also the 
application of 20 KV would terminate an enzyme reaction very quickly 7- 
OHC is detected after 0 9 nun usmg the CE method (Fig 3 5), but it 
takes up to 12 minutes usmg the LC method of Egan and O’Kennedy [21], 
this is also an important advantage of the method, as it means that many
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more samples can be run m a shorter tune m comparison with HPLC The 
speed of the CE separation is mainly due to the high efficiency that can be 
achieved by CE [23] Furthermore, up to 500 injections were made on to 
the CE capillary during these studies without any visible degradation of 
capillary performance If one compares the LOD of the available LC 
system [21] with the LOD of the CE system developed, there is little 
difference observed
Time(minutes)
Fig 3 10 Comparison of HPLC vs CE for the monitoring of 7-OHC 
formation by PI 7 microsomes
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3 2 2 4 NADP+/NADPH ratio study
Dimng this study, it was also discovered that it was possible to monitor an 
integral part of the monooxygenase reaction, 1 e the NADPH-dependent 
coumann metabolism reaction Usmg the capillary electrophoresis 
separation technique, one could follow the effect on both the NADP+ and 
the NADPH present during drug metabolism, as a result of the NADPH 
regeneration system m the mcubation mixture To slow down the 
production of the NADPH from NADP+, the concentration of the glucose- 
6-phosphate dehydrogenase was reduced to 0 1 U/ml as compared to 4 
U/ml for the metabolism study (otherwise the NADPH is formed too 
rapidly), all other conditions were as for the metabolism study PI 8 
microsomes were used for this ratio study The electrolyte for this work 
was 25 mM phosphate buffer, pH 7 5, to achieve a good peak shape for 
both NADP+ and NADPH
Fig 3 11 shows the electropherograms after 40 minutes of mcubation, of 
mcubation mixtures m (a) the absence and (b) the presence of coumann 
The absorbance ratio for NADP+/NADPH can be determined from this 
separation, and one can see the difference of having coumann present m 
the mcubation mixture With coumann present, more NADP+ is produced 
and hence NADPH is slower to be turned over by the NADPH 
regeneration system
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Fig 3 12 below shows a plot of NADP+/NADPH absorbance ratio versus 
time for the incubation mixture (a) and also for incubations m the absence 
of coumann (b), or microsomes (c) As can be seen from this figure, the 
ratio starts off high (>1) smce NADPH is only just bemg formed through 
the regeneration system As tune progresses, more NADPH than NADP+ 
is present and the ratio decreases
Fig 3 12 Plot of NADPVNADPH absorbance ratio versus time, for (a) the 
incubation mixture (1 e coumann present), (b) absence of coumann and
(c) absence of microsomes
1 0 4
As seen already from the control experiments (section 3 2 2 2), NADPH is 
utilised by the microsomes for other than the coumarm metabolism, 
possibly producmg a neutral compound by other biological processes This 
is also seen from plot B m Figure 3 12 Plot C shows how NADP+ is 
converted to NADPH m the absence of any draw on the NADPH Fig
3 12 is useful m that one can see clearly that when coumarm is bemg
\
metabohsed, the NADP+/NADPH ratio is quite different to when it is not 
present for metabolism, this may be of use when investigating whether a 
given drug is metabohsed using the NADPH dependent cytochrome P450 
system or not
3 2 2 5 Stability of NADPH
In the course of this work, it was also noticed that as mcubations were 
progressing, a compound was bemg produced with a slightly faster 
migration time than NADPH, and the concentration of this compound 
became progressively larger as the incubation neared its completion (Fig 
3 13) Further investigations were therefore earned out to determine how 
this compound was produced In one experiment, an incubation was 
performed with all the elements present (as m Experimental section) 
except the microsomes, with phosphate buffer taking their place to give the 
correct final volume Figures 3 14 (A-D) show how this compound is 
slowly formed over time Figure 3 15 shows the profile of peak height ratio 
of NADPH/unknown over 140 minutes of incubation Fig 3 16 shows a 
plot of peak height ratio of NADPH/coumann vs time, with the coumann 
acting as an internal standard m the incubation solution Controls showed 
coumann to be free from interference m these incubation mixtures The
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results show the NADPH peak to increase up to 40 minutes followed by a 
decrease in its concentration These results show NADPH to be falling m 
concentration as tune progresses and seems to be possibly degrading 
Smce all that is m the incubation solution is coumann, NADP+, NADPH, 
glucose-6-phosphate, and glucose-6-phosphate dehydrogenase, it should 
be easier to determine its origins m comparison to having the microsomes 
also present The products of the glucose-6-phosphate dehydrogenase 
enzyme reaction (reaction 1, section 3 2 2 1) are NADPH and nbose-6- 
phosphate The nbose-6-phosphate does not have a significant UV 
absorbance, and also the unknown m question is not produced at the same 
rate as NADPH, so it is clearly not a product of the enzyme reaction It is 
clear from the electropherograms where NADPH migrates, and this 
unknown has a migration time slightly faster than this This gives us the 
information that the unknown is slightly less negative in charge compared 
to NADPH It is conceivable that this unknown is a degradation product of 
NADPH, with NADPH possibly not bemg stable either m light, phosphate 
buffer or at 37°C Throughout this investigation, Sigma (from whom these 
chemicals were purchased) were contacted They suggested that the 
unknown may have been either adenosme-diphosphate, p-NADP or 
adenosme-monophosphate It is obvious that the unknown is not NADP+ 
from migration times Figure 3 17 shows the structure of adenosme 
diphosphate (ADP) From a comparison of this structure with that of 
NADP+ (Fig 3 6), it seems more probable that the unknown is adenosme 
diphosphate, rather than adenosme monophosphate (one less phosphate 
group), smce in theory AMP should migrate much faster than NADPH, 
bemg one phosphate group less negative and a much smaller molecule m 
size It is postulated that the reason ADP would migrate faster than
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NADPH is because of its smaller molecular weight, along with the extra 
negative charge associated with the hydroxyl groups of the nbose structure 
on the upper part of the molecule It may be possible that NADPH slowly 
degrades to ADP m phosphate buffer solution at 37°C A concentrated 
standard (10 mM) of NADPH was run under the electrophoretic conditions 
described above, but with a longer 50 cm capillary (other conditions as 
above) This is shown m Figure 3 18, which shows that NADP+ and an 
unknown are present in the Sigma standard This may be the same 
unknown as above, and this shows the value of capillary electrophoresis 
in running impurity profiles for quality control purposes
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T i m «  ( m l n )
Fig 3 13 Electropherograms showing how nnpunty near NADPH 
migration tune increases as incubation proceeds The figure shows 
nnpunty at the start of incubation (a) and after 45 mmutes (b)
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Fig 3 14 Conversion of NADP+ to NADPH after (a) 1, (b) 15, (c) 30 and
(d) 80 minutes of mcubation usmg the NADPH generation system
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Fig 3 15 Plot showing the peak height ratio of NADPH/unknown over 140 
minutes of mcubation (same incubation as in Figure 3 14 above)
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Fig 3 16 Plot of peak height ratio of NADPH/coumann vs tune, with the 
coumann acting as an internal standard in the incubation This data is 
taken from the same incubation as m Fig 3 14 above
i n
>>
NH_< *
Adenosine diphosphate
Fig 3 17 Structure of adenosine diphosphate
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Fig 3 18 Electropherogram of a 10 mM NADPH standard under the 
conditions as outlined in the experimental section, except usmg a longer 50 
cm capillary
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3 2 2 6  Interspecies differences in coumann metabolism
When carrying out the mterspecies investigations, the electrolyte used was 
50 mM phosphate buffer, pH 6  8 This proved to be the best electrolyte 
concentration and pH for the separation of components m the mcubation 
mixture
For this work a series of controls were carried out similar to those earned 
out m section 3 2 2 2 above, to show that the peak seen at the 7-OHC 
migration tune was m fact 7-OHC and not some other compound The 
senes of controls mcluded the withdrawal of the vanous members of the 
NADPH regeneration system, the absence of the hver microsomes and the 
absence of coumann Again it was not necessary to stop the reaction pnor 
to the analysis, as the application of the high voltage separated the 
individual components m the mcubation mixture, preventing further 
reaction A 10 jxl aliquot was removed at the specified time and added mto 
a microvial, from which it was analysed by capillary electrophoresis 
Again there was no need for the addition of the tnchloroacetic acid to 
precipitate the protem, as the method developed allowed the separation of 
the endogenous species m the sample from the an!alytes of mterest (Fig 
3 19)
The regeneration of the surface between every run also aided in 
maintaining the reliability of the method There was some mter-day 
vanability m the migration tunes for the different components, however, 
this was attnbuted to the day to day slight vanations m preparing the 
electrolyte buffer and was always less than ± 1 0 %
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Fig. 3.19 Electropherogram showing the separation of (A) coumarin, (B) 
7-OHC, (C) microsomes, (D) NADP and (E) NADPH. The separation was 
carried out on a 27 cm untreated silica capillary at 25 °C, using 50 mM 
phosphate buffer, pH 7.4, and UV detection at 214 nm.
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For some species (e g the cynomolgous monkey) the metabolism of 
coumann to 7-OHC proceeded linearly for the first 45 minutes The 
metabolism plateau’s after 45 minutes, as the activity of the microsomes 
(at 37°C) decreases All activity disappears if the microsomes are not 
stored correctly or mishandled during the in vitro assay When a 
comparison was made between the different species, the human liver 
microsomes demonstrated the highest coumann 7-hydroxylase activity 
(Table 3 3) However, the activity of the microsomes from the 
cynomolgous monkey are analogous with the human microsomal 
preparations studied The other species, however, have at least a ten-fold 
diminution m activity as compared with the human samples This work 
does show that different species do not predominantly metabolise 
coumann to 7-OHC, this is m agreement with other work m this area [22]
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Species (source) Microsomal protein 
concentration1 
(mg/ml)
7-hydroxycoumarm
concentration2
(nmol/ml)
Coumann 7- 
hydroxylase 
activity3 (pmol/mg 
protein/min
Rabbit (IFF A Credo) 13 7 13 0 2 1 1 0
Monkey (IFFA Credo) 14 5 45 1 6910
Bovine (self prepared) 26 9
(
14 0 1160
Porcine (self prepared) 1 1  2 0 0
Rat (IFFA Credo) 18 4 0 0
Mouse (CD1, self 
prepared)
7 5 0 0
Mouse (Sch self 
prepared)
16 5 0 0
Gerbil (self prepared) 1 2  6 114 2 0 1  0
Dog (IFFA Credo) 1 1 2 0 0
Human results
P13 16 0 62 37 8 6 6  3
P14 150 27 91 413 5
P17 14 4 42 35 653 5
P18 13 6 55 27 903 1
R1 18 9 73 78 867 5
Table 3 3 Comparison of species for Coumann 7-hydroxylase activity
1 Protein concentrations were determined by the BCA assay (see Experimental section)
2 The 7-OHC concentration was calculated at 45 minutes, which was defined as the 
time when the optimal activity of the microsomes decreased significantly, above which 
the metabolism profile was no longer linear
3 The coumann 7-hydroxylase activity was determined at 45 minutes
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3.3 ELECTROCHEMICAL INVESTIGATIONS INTO 
MICROSOMAL REACTIONS
3 3 1 EXPERIMENTAL 
3 3 1 1  Chemicals
NADPH, flavin adenine dinucleotide (FAD) and flavin mononucleotide 
(FMN) were purchased from Sigma (St Louis, MO) Coumann was 
donated by Schaper and Brummer Sodium dithiomte was purchased from 
Sigma Phosphate buffer (0 1M, pH 7 5) was prepared daily by dissolving 
0 08M K2HP04 and 0 0 2M KH2PO4 in deiomsed water
3 3 12 Tissue preparation
The same microsome preparations were used as already described m 
section 3 2 12 Genetically engineered homogenate from V79 cells 
expressmg rat CYP 1A2 with a protem concentration of 4 mg/ml was 
donated by Prof Johannes Doehmer, Department of Toxicology, 
University of Mainz, Germany
3 3 13 Apparatus
The instrumentation used for this work mvolved a conventional three 
electrode system with glassy carbon, silver/silver chloride and platinum 
wire as working, reference and counter electrodes respectively These 
were connected to a BAS-50W voltammetnc analyser Unless otherwise
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stated, all electrochemical investigations were earned out in a small cell 
containing 10 ml of 0 1 M, phosphate buffer, pH 7 5
3 3 14 Electrochemical methods
Cyclic voltammetry was predominantly used in the electrochemical 
investigations Scan rates, and initial and final potentials were optimised 
during the studies m both the positive and negative potential regions Pnor 
to use the glassy carbon electrodes were always electrochemically 
pretreated by multi-cycling m phosphate buffer to reduce background 
currents Incubation studies were earned out on solutions containing 2 mM 
coumann, 1 mM NADPH and 2 mg/ml protem concentration of human 
microsomal suspension This was made up by adding 34 (il of 10'2M 
coumann, 136 ml of 0 1 M, phosphate buffer, pH 7 5, 10 jxl of 20 mM 
NADPH and finally 20 p.1 of human microsomal suspension (giving 
approximately 2 mg/ml protem concentration) Investigations were also 
earned out in the absence of coumann and/or microsomes Studies were 
earned out to optimise the electrochemical response from the microsomes 
by investigating how best pre-concentration of the microsomes could be 
achieved For the electrochemical work, the studies were earned out 
between 0 and +1 0 V (vs Ag/AgCl) in the anodic region, and between 0 
and -10 V (vs Ag/AgCl) m the cathodic region As well as cychc 
voltammetry, differential pulse voltammetry was also used to provide 
better sensitivity m some studies All potentials m this work were with 
respect to a Ag/AgCl reference electrode
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3 3 2  RESULTS AND DISCUSSION
The initial aim of this work was to develop a biosensor capable of 
monitoring the cytochrome P450-catalysed metabolism of specific 
compounds This effort was unsuccessful for a number of reasons, as will 
be discussed, however, some interesting observations were made from 
these investigations and these will be discussed below The 
electrochemical work is divided mto work in the anodic region, and work 
in the cathodic region
3 3 2 1 Investigations m the anodic region
Initial studies involved direct electrochemistry of the microsome 
suspensions to investigate if any electrochemical responses could be 
detected Figure 3 20 shows a cychc voltammogram of a solution which 
contains 20 fxl of human microsomal preparation ( from patient R6 ) and 
170 jal of 0 1 M, phosphate buffer, pH 7 5, at a bare glassy carbon surface 
The scan was between 0 and +1 0 V at a scan rate of 15 mV/s This figure 
shows two oxidation peaks at approximately +0 40 and +0 75 V 
respectively The peak at +0 75 V is very pronounced while the peak at 
+0 40 V is quite faint These two oxidation peaks were found m all the 
human liver microsome preparations Scans were also undertaken at more 
positive potentials, but no extra peaks were detected A study was 
undertaken to try to detect these oxidation processes with greater 
sensitivity These efforts mcluded trying to immobilise the microsomal 
preparation at the glassy carbon surface with Nafion and glutaraldehyde, 
but it seemed that these two immobilisation techniques retarded the flow of
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electrons and very small currents were detected It was found that 
dropping 5 |J.l of microsomal suspension onto the glassy carbon electrode 
surface and allowing this to dry for 1 hour before running the cyclic 
voltammogram (under the same conditions, m l O m l o f O l M  phosphate 
buffer, pH 7 5) proved the most successful The cychc voltammogram 
(CV) for such a system is shown m Figure 3 21 Unfortunately the scan 
had to be taken very quickly as the microsome preparation was seen to 
dislodge from the electrode quickly, and only one scan was possible with 
this procedure
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P o te n t i a l / V
Figure 3 20 Cyclic voltammogram of a solution which contains 20 jil of 
human microsomal preparation ( from patient R6 ) and 170 |al of 0 1M 
phosphate buffer, pH 7 5, at a bare glassy carbon surface The scan was 
between 0 and +1 0 V at a scan rate of 15 mV/s
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Fig 3 21 Cyclic voltammograms of (a) human microsomal suspension 
after 5 |il of microsomal suspension was dropped onto a glassy carbon 
electrode surface and (b) genetically engineered cells, after 5 jxl of 
genetically engineered homogenate was dropped onto a glassy carbon 
electrode surface and each allowed to dry for 1 hour
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Figure 3 21 shows that the oxidation peaks are seen more clearly now at 
approximately +0 40 and +0 75 V An experiment was also earned out by 
dropping 5 (0.1 of homogenate from genetically engineered V79 cells 
(expressmg CYP 1A2) onto a clean glassy carbon electrode, allowing this 
to air dry for 1 hour and running a cychc voltammogram as above This 
CV is also shown m Fig 3 21 It shows that one of the oxidation peaks 
( + 0  75 V) is also seen m the genetically engineered fraction Differential 
pulse voltammetry was used to try to detect these oxidative peaks with 
more sensitivity, and this was performed by dropping 5 jxl of R6  
microsomal preparation onto the clean glassy carbon electrode, allowing to 
dry for 1 hour and followed by a differential pulse scan between 0 0 and 
1 0 V, at 15 mV/s This is shown m Figure 3 22 below It shows more 
definitely that two oxidation peaks are present m the general microsome 
preparations Work was then performed to try to determine the ongin of 
these oxidation peaks It was initially thought that these peaks were due to 
electrochemical reactions of some proteins m the microsome suspensions, 
but this was discounted when after boiling a solution of the microsome 
suspension (50 pi of microsomes + 1 0 0  p.1 phosphate buffer) for 30 
minutes, the oxidation peaks were still present Any protem should have 
been denatured after this treatment
After some study mto what the peak at +0 75 V was due to, NADPH was 
thought to be a possibility, and Fig 3 23 shows 3 voltammograms of 3 
solutions which contains (a) 170 p.1 of pH 7 5, 0 1M phosphate buffer and 
20 (0.1 of R6  microsome suspension, (b) same as (a) with 0 2 mM of 
NADPH spiked mto it, and (c) a CV which was performed with a glassy 
carbon electrode which had 5 jxl of the genetically engineered cells dned 
on it for 1 hour pnor to scanning in phosphate buffer, 0 1M, pH 7 5 The
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CVs were scanned between 0 0 and +10 V, at 15 mV/s NADPH is 
oxidised in this region as will be seen later
P o t e n t i a l / V
Fig 3 22 Differential pulse voltammogram of a glassy carbon electrode 
which had 5 p.1 of R6 microsome suspension dropped onto and dried for 1 
hour, prior to scanning It was scanned from 0 0 and +1 0 V at 15 mV/s in 
10 mis of 0 1 M, phosphate buffer, pH 7 5
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Fig 3 23 Voltammograms of 3 solutions which contain (a) 170 fil of 0 1 
M phosphate buffer, pH 7 5, and 20 jj.1 of R6 microsome suspension, (b) 
same as (a) with 0 2 mM of NADPH spiked mto it, and (c) a CV which 
was run with a glassy carbon electrode which had 5 jj.1 of the genetically 
engineered cells dried on it for 1 hour prior to scanning m 0 1 M 
phosphate buffer, pH 7 5 The CVs were scanned between 0 0 and +10 
V, at 15 mV/s
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This figure shows that the oxidation peak at +0 75V could be due to 
native NADPH in the microsomes and genetically engineered cells More 
evidence towards this theory was obtained when an experiment was 
earned out, when after recording CVs (under the same conditions as 
above) of a human hver microsome suspension (50 fil of R1 + 100 p.1 
0 1M, phosphate buffer, pH 7 5) at tune 0 and after 120 minutes at room 
temperature, the oxidation peak at 0 75V was seen to disappear This is 
shown m Figure 3 24 This has already been seen to happen when NADPH 
was incubated m the presence of microsomes (see sections 3 2 2 2 and 
3 2 2 4) It is used up m natural biological processes m the microsomes 
This was seen to happen here over 120 minutes even at room temperature 
(20°C) It must also be remembered that the peak did not disappear when 
the microsome solution was rapidly boiled for 30 minutes This would 
have destroyed any protein, hence NADPH would not be used up by 
protem related reactions m the microsomes This result seems to suggest 
that the peak at +0 75V may be due to native NADPH m the microsomes 
but further proof would be needed for this No experiments were able to 
suggest what the peak at +0,40 V was due to
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Fig 3 24 Cyclic voltammograms of a human liver microsome suspension 
(50 jul of R1 + 100 jj.1 0 1M, phosphate buffer, pH 7 5) at (a) tune 0 and 
(b) after 120 minutes at room temperature Scan taken between 0 0 and 
+1 0 V at 15 mV/s
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3 3 2 2 Study of incubation reactions using cyclic voltammetry
By monitoring the NADPH present in an microsomal mcubation solution 
using cyclic voltammetry, it was possible to follow the disappearance of 
this cofactor, just as it was by using capillary electrophoresis A series of 
experiments were designed and the results found were very similar to that 
found using CE
An interesting experiment earned out was the mcubation of 20 (¿I of 
human liver microsome preparation R6  (in 170 pi of 0 1 M, phosphate 
buffer, pH 7 5) with 1 mM NADPH at 37 °C It is worth noting that there 
is no substrate to cytochrome P450 present m this solution This mcubation 
was momtored by running a cyclic voltammetnc scan between 0 0 and 
+1 0 V at 15 mV/s at the start of the mcubation and after 20 minutes of 
mcubation (see Fig 3 25) This voltammogram shows that NADPH is used 
up by cellular processes m the microsomes even m the absence of any 
substrate to cytochrome P450 This is similar to the result that we have 
also seen usmg capillary electrophoresis (see sections 3 2 2 2 and 3 2 2 4) 
Fig 3 26 shows a CV (under the same conditions as above) of 1 mM 
NADPH m 0 1 M, phosphate buffer, pH 7 5, before and after 20 minutes 
of mcubation at 37 °C This shows that the above observation is not 
decomposition of NADPH but the utilisation of the cofactor in cellular 
processes The reason for the shift m potential between Figs 3 25 and 3 26 
is probably due to the NADPH bemg m significantly different matnces 
(microsomes versus buffer)
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Fig 3 25 Incubation of 20 |_il of human liver microsome préparation R6 (m 
170 pi of 0 1M, phosphate buffer, pH 7 5) with 1 mM NADPH at 37 °C 
This mcubation was monitored by runnrng a cychc voltammetnc scan 
between 0 0 and +1 0 V at 15 mV/s at (a) the start of the incubation and 
(b) after 2 0  minutes of mcubation
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Fig 3 26 Cyclic voltammogram (under the same conditions as Fig 3 25) 
of 1 mM NADPH m O l M ,  phosphate buffer, pH 7 5, (a) before and (b) 
after 20 minutes of incubation at 37 °C
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As outlined already, the initial aim was to develop a biosensor capable of 
monitoring cytochrome P450 enzyme reactions With reference to the 
equation
P450
NADPH + FT + 0 2 + SH --------- > NADP+ + H20  + SOH (1)
any attempt to design a biosensor with a view to monitoring cytochrome 
P450 enzyme reactions would fail if the sensor were to utilise the 
appearance or disappearance of NADPH, for the reason that NADPH is 
used by many cell processes Also, oxygen or hydrogen ion consumption 
could not be made use of m constructing a sensor, smce these are also 
used m numerous cell reactions The best approach to constructing a 
biosensor to follow cytochrome P450 would be to directly momtor the 
change m redox states of the heme group m the P450 enzyme
3 3 2 3 Investigations in the cathodic region
Investigations were also earned out m the cathodic region to study if any 
electrochemical responses could be detected m this region Electrolytes in 
this region were deaerated with nitrogen pnor to CV, as otherwise the 
reduction of oxygen would mask any small electrochemical response 
Figure 3 27 shows the cychc voltammogram of a solution which contains 
200 p.1 of human hver microsomes (R6 ) + 100 |il of 0 1M, phosphate 
buffer, pH 7 5 This solution was de-aerated for 15 minutes by gently 
bubblmg nitrogen through it, followed by scanning between 0 0 and -1 0 V
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(vs Ag/AgCl) at 200 mV/s It shows that a redox couple is detected at 
approximately -0  40 V (vs Ag/AgCl) This redox couple was detected in 
all of the human liver microsomes, with the currents observed varying 
between microsomes from different patients Investigations were earned 
out to try to identify the ongm of the redox couple
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Figure 3 27 Cyclic voltammogram in the cathodic region of a solution 
which contains 200 pi of human hver microsomes (R6 ) + 100 jxl of 0 1M, 
phosphate buffer, pH 7 5 This solution was deaerated for 15 minutes by 
gently bubblmg nitrogen through it, followed by scanning between 0 0 and 
-1 0 V (vs Ag/AgCl) at 200 mV/s
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An interesting experiment was earned out by incubating 50 pi of human 
liver microsomes (R6  preparation) + 100 pi 0 1M, phosphate buffer, pH 
7 5, with 2 mM coumann and 1 mM NADPH A cyclic voltammetnc scan 
was run after 45 minutes of incubation at 37 °C, after de-aeration Figure 
3 28 shows the CV obtained It also shows a CV of the R6 microsomal 
suspension (50 pi + 100 pi of 0 1M, phosphate buffer, pH 7 5) in the 
absence of substrate and cofactor, under the same conditions The figure 
shows that the redox couple is affected by the incubation with substrate 
and cofactor, and this redox couple effectively disappears after incubation 
for 45 minutes The redox couple is also affected by the presence of the 
reducing agent sodium dithiomte (SDT) When 1 mM of SDT was added 
to the microsomal suspension (50 pi of preparation R1 + 100 pi of 0 1M, 
phosphate buffer, pH 7 5), the currents from the redox couple were 
considerably reduced (Fig 3 29) The CVs were run between -0 20 and - 
0 80 V at 600 mV/s This observation was interesting because SDT is used 
m cytochrome P450 investigations to reduce the heme group from Fe(m) 
to Fe(H)
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Fig 3 28 Incubation of 50 pi of human hver microsomes (R6  preparation) 
+ 100 jj.1 0 1M, phosphate buffer, pH 7 5, with 2 mM coumann and 1 mM 
NADPH Cychc voltammetnc scan was run after 45 minutes of mcubation 
at 37 °C, after deaeration This figure also shows a CV of the R6  
microsomal suspension (50 fxl + 100 pi of 0 1M, phosphate buffer, pH 
7 5) m the absence of substrate and cofactor, under the same conditions, 
these conditions being a CV scan between 0 0 and -1 0 V at a scan rate of 
600 mV/s
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Fig 3 29 Cyclic voltammogram before and after 1 mM of SDT was added 
to the microsomal suspension (50 jil of preparation R1 + 100 pi of 0 1M, 
phosphate buffer, pH 7 5),
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It may be possible that the heme group of the cytochrome P450 is bemg 
detected m this experiment, but it is also possible ( and probably more 
likely) that the redox couple in the above cyclic voltammograms is due to 
the presence of cytochrome P450 reductase in the endoplasmic reticulum 
(microsomal) cytochrome P450 system Cytochrome P450 reductase is 
bound by its hydrophobic tail to the membrane whereas cytochrome P450 
is deeply embedded in the membrane [1] Hence the heme group is 
extremely difficult to access and it is more likely that electrons can be 
transferred more easily to the reductase As mentioned already (section 
313), cytochrome P450 reductase contains both flavin adenine 
dinucleotide (FAD) and flavin mononucleotide (FMN) groups The FAD 
serves as an entry pomt for electrons from NADPH, and FMN serves as 
the exit pomt, transferring electrons individually to cytochrome P450 
Figure 3 30 shows a CV of 5 mM FMN (prepared m 0 1M pH 7 5 
phosphate buffer) between 0 and -IV at 100 mV/s FMN has a redox 
couple centred at -0  44V Figure 3 31 shows a CV of 1 0  mM FAD 
(prepared m 0 1M phosphate buffer, pH 7 5) between 0 0 and -1 0 V at 
100 mV/s It is possible that if the cytochrome P450 reductase is 
accessible then we could be able to detect electron transfer between the 
reductase and the electrode surface, however much more work would have 
to be done to conclusively prove this Along with these investigations 
other working electrodes, e g platinum and gold, were investigated in an 
effort to obtain more sensitivity m detecting the redox couple, but these 
were less successful than glassy carbon Also surface modifiers on these 
working electrodes, e g L-lysme, were utilised, but again with no success
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Figure 3 30 Cyclic voltammogram of 5 mM FMN (prepared in 0 1M 
phosphate buffer, pH 7 5) between 0 0 and - 1  0 V at 100 mV/s FMN has 
a redox couple centred at -0 44V
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Figure 3 31 Cyclic voltammogram of 10 mM FAD (prepared in 0 1M 
phosphate buffer, pH 7 5) between 0 0 and -1 0 V at 100 mV/s
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3.4 CONCLUSIONS
The above chapter has utilised two analytical techniques, capillary 
electrophoresis and cyclic voltammetry, to study metabolism reactions 
involving liver microsomes Capillary electrophoresis was utilised to 
momtor the formation of 7-OHC by human hver microsomes without the 
need to stop the cytochrome P450 enzyme reaction Significant advances 
were also made due to the fact that it was not necessary to add 
trichloroacetic acid to precipitate the protem prior to analysis This is a 
considerable advantage compared to the HPLC methods used to date It 
was shown that CE proved a useful technique and an alternative to HPLC 
m the monitoring of cytochrome P450 reactions
What was also noticed throughout the work was that the cofactor for the 
cytochrome P450 reaction (NADPH) could also be momtored as the 
incubation progressed This is also an advantage compared to existing 
technology Some interesting observations were made about the cofactor, 
and it became clear that the cofactor was used for a number of processes 
m the hver microsomes It was also shown from the NADP/NADPH ratio 
studies, that it was possible to use this ratio to determine if a compounds 
metabolism used NADPH as the cofactor The stability of the NADPH 
was also studied and it was postulated that the cofactor is not stable m 
phosphate buffer at 37°C for long periods
A
Capillary electrophoresis was also used for the study of mterspecies 
differences of coumann metabolism, and the findings from the work 
agreed with other work in the area, 1 e that the cynomolgous monkey 
proved to be the species most closely resembling the human metabolism of 
coumann
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Electrochemistry also proved useful m the study of hver microsomal 
reactions Investigations m the anodic region showed the presence of 
oxidation peaks, one of which may have been native NADPH m the 
microsome suspension However, further work would be needed to 
conclusively prove this In the cathodic region a redox couple was 
detected, and although again it was not possible to explain its origins it 
could be due to the presence of cytochrome P450 reductase in the 
microsome suspensions Again much more work needs to be done to be 
sure of any explanation The electrochemical work with the microsomes is 
made very difficult due to the fact that signals are very faint This is 
primarily due to microsomes containing all the components of cells which 
will mask any signal
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CHAPTER 4
DETERMINATION OF 7 - HYDROXYCOUMARIN USING A 
HORSERADISH PEROXIDASE LABELLED ANTI -7 - 
HYDROXYCOUMARIN ANTIBODY-BASED BIOSENSOR
146
4.1 INTRODUCTION
Immunological techniques are particularly suited to the detection of low 
level concentrations of analytes m biological matrices In the 
determination of low levels of analytes there are two main requirements
(I) a sensitive assay, and (2) high selectivity Immunosensors take 
advantage of the high selectivity provided by the molecular recognition of 
an antigen by its specific antibody In principle, antibodies of high affinity 
may be produced against any antigen Immunosensors are thus 
characterised by high selectivity, sensitivity and versatility In the design 
of immunosensors (or any molecular sensor) two phenomena must be 
combmed
(i) the selective molecular recognition of the target molecule an important 
factor is the intrinsic selectivity of the biological material mvolved in the 
recognition process, as problems of interference may occur m complex 
samples,
(II) the occurrence of a physical or chemical signal consecutive to the 
molecular recognition event, where the transduction mode can be either 
electrochemical, thermal or optical in nature or based on a change m mass
High sensitivity, as well as high selectivity and reproducibility, are 
essential requisites for immunosensors Antibody properties for biosensor 
applications have been reviewed [1 ], together with future trends and future 
aspects of the research and development of immunosensors [2 ]
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Along with these there have been a number of other reviews concerning 
antibody-based biosensors [3-7] The selective reaction between an 
analyte and the corresponding antibody ensures the high specificity of the 
lmmunosensor m biological fluid analysis The specificities of 
immunosensors are determined m part by the affinity constants of the 
antibody-antigen interactions [8] While a high affinity constant will give 
rise to high specificity, too high an affinity constant will result m an 
irreversible reaction, unless protem denaturing conditions are used 
The major processes mvolved in any biosensor system m Fig 4 1 [9] 
There are a number of ways m which the binding event can be transduced 
mto a measurable signal Typical transducers mclude electrochemical, 
optical, acoustic and semiconductor devices
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Analyte
4*
External Interface
Biological recognition system 
IC
Bioaffinity Biocatalysis
*  a  u  *
Antibody DNA Receptor Enzyme Tissue Cell/Organelle
Internal interface
4*
Transducer
Physico-chemical response
l£ *  ^
H+ Ions e* Light Mass Heat
Fig 4 1 Scheme representing the processes taking place m a typical 
biosensor system (Reproduced from reference [9])
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4 1 1 IMMUNOSENSORS BASED ON OPTICAL DEVICES
In a surface plasmon resonance (SPR) immunosensor system, when the 
antigen binds, minute changes m the refractive mdex of the SPR device are 
detected as a shift in the angle of total absorption of light incident on a 
metal layer containing immobilised antibodies The SPR device can 
consist of a prism or a glass slide carrying the thin metal layer Recently, 
Morgan and Taylor [10] have developed a surface plasmon resonance 
immunosensor based on the streptavidm-biotm complex Nice et al [1 1 ] 
have published work on the mapping of the antibody and receptor-binding 
domains of granulocyte colony-stimulating factor using an optical 
biosensor The data was obtained using a BIAcore biosensor, with surface 
plasmon resonance detection
A BIAcore biosensor was also developed for the analysis of 7-OHC in 
biological samples [12] The BIAcore sensor system utilises a combination 
of optical and continuous flow technologies to facilitate interaction 
analysis Biomolecular binding can be studied by immobilising one of the 
components on the surface of a specialised sensor chip within the 
biosensor, and allowing the other to flow over the surface in solution 
Mass changes at the biosensor chip surface due to the binding of two or 
more components causes a change m the resonance angle directly 
proportional to the mass change In the 7-OHC BIAcore biosensor, 7- 
OHC-bovme serum albumin was first immobilised on the sensor chip 
surface A 20 ml volume of antibody-sample mixture was then injected 
mto the system The 7-OHC-BSA conjugate immobilised on the sensor 
surface and the 7-OHC m the sample compete for the antibody binding 
The resulting signal due to the unbound antibody binding to the drug
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protein conjugate immobilised on the sensor chip is mversely proportional 
to the amount of 7-OHC present in the sample The range of the assay was 
quoted to be from 0 5 - 80 pg/ml
Optical immunosensors can also be based on internal reflections m a 
waveguide with antibodies immobilised on the surface of the guide which 
is in contact with the analyte Use can then be made of the evanescent 
wave penetrating a fraction of a wave-length into the optically rarer 
medium when light coming from a denser medium is mcident on the 
interface with an angle above the critical angle Fluorescent techniques 
can be used to good advantage with these devices Bright [13] has 
reported on probing biosensor interfaces, by multi-frequency phase and 
modulation total-internal reflection fluorescence There are quite a number 
of immunosensors m the recent literature usmg the fiber optic approach 
[14,15] For example, Bier et al [16] have made use of a fiber optic 
immunosensor for the detection of certain pesticides Ammohexylatnazme 
was immobilised on one end of a silica fiber and the fiber was inserted into 
a flow-through glass cell Tnazme antibodies (conjugated with fluorescein 
isothiocyanate) were detected after binding to the fiber surface based on 
the decrease m the fluorescence signal caused by the presence of tnazmes 
due to the inhibition of antibody binding to the fiber
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DEVICES
4 1 2 IMMUNOSENSORS BASED ON SURFACE ACOUSTIC WAVE
Surface acoustic wave (SAW) devices, which can be sensitive to changes 
m the elasticity, density or electrical conductivity of a surface on which a 
surface acoustic wave propagates, can also be used as immunosensors 
The device usually consists of a piezoelectric crystal, such as quartz 
carrying thin-film mterdigitated electrode arrays Radiofrequency 
excitation of the electrode pan creates a synchronous mechanical surface 
wave, which is propagated on the surface of the piezoelectric substrate and 
received by another electrode pair Koemg and Graetzel [17] have used a 
piezoelectric immunosensor for the detection of human T-lymphocytes 
The frequency difference between the coated crystal (coated with 
antibody) and a reference crystal was first measured, then the coated 
biosensor was placed m a solution of human T-lymphocytes and a second 
frequency difference was measured
Prusak-Sochaczewski and Luong [18] have also used a piezoelectric 
crystal immunosensor for the determination of human serum albumin The 
sensor was prepared by coating the crystal with protem A and reacting this 
with anti-human serum albumin antibody This surface could then be used
m the determination of human serum albumin1
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4 1 3 IMMUNOSENSORS BASED ON SEMICONDUCTOR DEVICES
In linmuno field effect transistors (ImmunoFETs), the gate of an ion 
selective field effect transistor is covered with an antibody-containing 
membrane They can be constructed for the detection of the minute 
potential changes associated with the formation of the antibody-antigen 
complex An example of an immunoFET was developed by Schasfoort et 
al [19], who reported on an immunosensor to momtor the immunological 
reaction between human serum albumin and its antibody
4 1 4 IMMUNOSENSORS BASED ON ELECTROCHEMICAL
TRANSDUCERS
Electrochemical measurements for immunosensmg fall mto two broad 
classes, (i) amperometnc devices and (u) potentiometnc devices 
Amperometnc devices mvolve the measurement of the current flowing 
between two electrodes in response to the application of a fixed potential 
In contrast, potentiometnc devices require the denved voltage to be 
determined with reference to a second electrode under conditions of zero 
current flow
In terms of potentiometnc mununoelectrodes, Blackburn et al [20] have 
recently descnbed a biosensor employing catalytic antibodies as the 
molecular recognition element In their system, a pH microelectrode was 
modified with a monoclonal antibody that catalysed the hydrolysis of
153
phenyl acetate to produce protons which would then be sensed at the 
potentiometnc electrode
Some recently developed amperometnc immunosensors mclude a sensor 
for the determination of chohnesterase [2 1 ] and immunosensors based on 
electropolymensed poly(tyramine)-modified electrodes [22] Recently, 
Sadik and Wallace have used pulsed amperometnc detection for the 
determination of human serum albumin using an antibody-containing 
conducting polymer [23]
Dempsey et al [24] developed an immunosensor based on the use of anti- 
7-OHC antibodies immobilised at the surface of a glassy carbon electrode 
behind a permeable cellulose dialysis membrane When the antibody was 
present at the electrode surface, there was a significant decrease m the 7- 
OHC electrochemical response The binding of the antigen to the antibody 
was beheved to occur at the electroactive site of the drug Anodic 
detection of the oxidised product was achieved at 0 60 V usmg DC 
amperometry
In work earned out by the candidate as part of his Ph D studies, but not 
reported in detail m this thesis, a novel amperometnc immunosensor was 
developed for the quantitation of Factor Vm, a glycoprotein whose 
concentration is important m the diagnosis of haemophilia [25] The 
method was based on the decrease in current observed when free Factor 
Vm competes with Factor VIE immobilised on a glassy carbon electrode 
for specific anfi-Factor Vm antibody labelled with horseradish 
peroxidase Current was found to be mversely proportional to the 
concentration of Factor VUI m solution The enzyme horseradish
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peroxidase (HRP) catalyses the reaction between hydrogen peroxide and 
hydroquinone, and electrochemical biosensmg was based on the 
amperometnc monitoring of the electrochemical reduction of the oxidised 
mediator, benzoqumone
The purpose of this present study was to develop an amperometnc 
immunosensor for the determination of 7-hydroxycoumann usmg 
horseradish peroxidase labelled anti-7 -hydroxycoumann antibody, which 
would be easier to prepare m companson to the immunosensor of 
Dempsey et al [24] and would function with a similar principle to that of 
the Factor VIII immunosensor descnbed above [25]
4.2 EXPERIMENTAL 
42  1 APPARATUS
A conventional 3 electrode system, with glassy carbon, saturated calomel 
and platinum gauze as working, reference and counter electrodes 
respectively, was connected to an EG&G PAR (Princeton Applied 
Research, Pnnceton, NJ, USA) Model 264A polarographic analyser with 
output currents bemg measured by a WPA (Linton, Cambndge, UK) 
Model CQ95 recorder A batch amperometnc mode of operation was used 
throughout, with a magnetic stiiTer and bar providing the convective 
transport A heat gun was used in the electrode preparation and an 
mcubator (Memmert, West Germany) was used m the temperature studies
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4 2 2  ELECTRODE PREPARATION
Before use, the bare glassy carbon electrode was first polished with 
alumina slurry, after which it was sonicated m distdled water, nnsed with 
distilled water and allowed to dry m air Modification of the electrode was 
achieved via drop coating of a 1 0  pi aliquot of the appropriate amount of 
conjugated protein (ovalbumin-7-OH-coumann or thyroglobuhn-7-OH- 
coumann) m 5% Nafion, onto the electrode surface The modified 
electrode was then dried for 1 hour usmg the heat gun
In the course of the optimisation studies the modified electrode was 
mcubated m the appropriate concentration of HRP-labelled anti-7-OH- 
coumann antibody (m 0 1 M phosphate buffer, pH 7 3) at the required 
temperature for 60 minutes During the competitive assay, the modified 
electrode was mcubated m a solution of anti-7 -OH-coumann antibody 
[made up in 0 1M phosphate buffer, pH 7 3] and the appropnate 
concentration of free 7-OH-coumann (10 mM stock solution made up m 
90 1 0  water-methanol daily)
4 2 3  PROCEDURES
The modified electrode was then nnsed m 0 1 M phosphate buffer, pH 7 3, 
and introduced into the electrochemical cell DC amperometry was earned
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out at a potential of -0 03 V Vs SCE after purging the phosphate buffer 
electrolyte solution (pH 7 3) with oxygen-free nitrogen for 20 minutes The 
hydroqumone mediator (0 1 M stock solution made up m 0 1 M phosphate 
buffer immediately prior to use) was injected mto the cell to reach a final 
concentration of 2 mM and the hydrogen peroxide substrate was added to 
give a final concentration of 1 mM m the cell The reduction current of the 
oxidised mediator was then measured
4 24 REAGENTS
Batch experiments were conducted at room temperature in 01 M 
phosphate buffer (pH 7 3), and all solutions were prepared m deionised 
water obtained by passmg distilled water through a Milh-Q water 
purification system (Milhpore, Milford, MA, USA) 7-hydroxycoumann 
(Umbelhferone) was purchased from Sigma (St Louis, MO, USA) The 
anti-7 -OH-coumann antibodies were raised in rabbits [26] and the HRP-
labelhng was carried out according to Tyssen [26] A 5 mg ml'l solution 
of the HRP-labelled antibody was diluted with 0 1 M phosphate buffer, pH 
7 3 Diazotisation and conjugation of 7-OH-coumann to BSA, ovalbumin 
and thyroglobuhn was performed using a modification of methods reported 
by Morgan et al [27] and Baker et al [28]
Potassium dihydrogen phosphate and dipotassium hydrogen phosphate 
were obtained from Riedel-de-Haen (Hannover, Germany) Methanol 
(HPLC grade) was obtamed from Labscan (Dublin, Ireland) 
Hydroqumone was purchased from the Aldnch (Dorset, UK) Nafion
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(perfluonnated ion-exchange powder, 5% solution in lower aliphatic 
alcohol's and 10% water) was purchased from the Aldnch (Dorset, UK) 
Hydrogen peroxide was obtained from Riedel-de-Haen (Hannover, 
Germany) A 0 1 M solution of hydrogen peroxide was made up daily m 
0 1 M phosphate buffer, pH 7 3
4.3 RESULTS AND DISCUSSION 
43  1 SENSING MECHANISM
The enzyme horseradish peroxidase (HRP) catalyses the reaction between 
hydrogen peroxide and hydroqumone (HQ), and electrochemical 
biosensmg is based on the amperometnc monitoring of the electrochemical 
reduction of the oxidised mediator benzoquinone (BQ) [29]
HRP
(1) H20 2 + HQ > 2H 20 + BQ
Applied Potential
(2) BQ + 2H+ + 2e- - > HQ
(-0  03 V)
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4 3 2 DEVELOPMENT OF AN OVALBUMIN-7-OH-COUMARIN
MODIFIED ELECTRODE
A 15% (w/v) ovalbunun-7-OH-coumann modified electrode was prepared 
as described m the Experimental section This modified electrode was then
incubated in a 0 33 mg mH anti-7-OH-coumann antibody solution at 37 0 
C for 1 hour, after which it was rinsed with 0 1 M phosphate buffer (pH 
7 3) The steady state response of this modified electrode to successive 
additions of 1 mM H2 O2 , m the presence of 2 mM hydroqumone as
mediator, is shown in Fig 4 2 (a)
The steady state response for the control electrode (ovalbumin only on 
surface) is shown m Fig 4 2 (b) This demonstrates that there is a 
significant interference at this protein modified electrode This was not 
entirely unexpected as the rabbits were initially immunised with a bovine 
serum albumin (BSA) -7-OH-coumann conjugate [26] and some of the 
antibodies produced have an affinity for BSA itself Ovalbumin is a very 
similar protein to BSA [30] (both bemg albumins), and this would be likely 
to explain the high response for the control electrode Globulins are 
significantly different proteins compared to albumins [30], and therefore, 
a thyroglobuhn-7-OH-coumann conjugate was synthesised [27,28], and a 
thyroglobuhn modified electrode was compared to the ovalbumin modified 
electrode
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Time ( min }
Time £ min }
Fig 4 2 Current-time response for successive 1 mM injections of H2 O2  at
(a) ovalbumin-7 -OH-coumarm modified electrode and (b) ovalbumm-only 
modified electrode, m a solution containing 2 mM hydroquinone 
Operating potential -0 03 V with 450 rpm stirring rate Electrolyte, 0 1 M 
phosphate buffer, pH 7 3 The modified electrodes had first been mcubated
in a 0 33 mg mH anti-7-OH-coumann antibody solution for 1 hour at 37° 
C
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4 3 3 DEVELOPMENT OF A TH YROGLOBULIN-7-OH-COUMARIN
MODIFIED ELECTRODE
These modified electrodes were prepared in a similar way to those using 
ovalbumin A 15% (w/v) thyroglobulm-7-OH-coumann modified electrode 
was prepared and mcubated m a 0 33 mg ml-1 solution of anti-7-OH- 
coumann antibody for 1 hour at 37 °C Fig 4 3 (a) shows the steady state 
current response of this modified electrode to successive additions of 1 
mM H2 O2  ( m the presence of 2 mM of mediator) It can also be seen
from this figure that introduction of the mediator mto the electrochemical 
cell produces no response Fig 4 3 (b) shows the response of a 15% (w/v) 
thyroglobulm modified control electrode The resulting calibration plot for 
the thyroglobuhn-7-OH-coumann modified electrode is shown in Fig 4 4 
These results suggest that the anti-7-OH-coumarm antibodies have much 
less affinity for the thyroglobulm protein compared to ovalbumin and for 
the remainder of the work the thyroglobulm conjugate was used in the 
development of an immunosensor for 7-OH-coumann
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Fig 4 3 Current-time response for successive 1 mM injections of 
H2 O2  at (a) thyroglobulin-7-OH-coumann-modified electrode and
(b) thyroglobulin-modified electrode, in a solution containing 2 mM 
hydroqumone Operating potential -0 03 V with 450 rpm starring rate 
Electrolyte 0 1 M phosphate buffer, pH 7 3 The modified electrodes had
first been mcubated in a 0 33 mg mH anti-7-OH-coumann antibody 
solution, for 1 hour at 37°C
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Concentration of hydrogen peroxide (mM)
Fig 4 4 Calibration plot for 15% (w/v) thyroglobuhn-7-OH-coumann- 
modified electrode Conditions as in Fig 4 3
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The effects of many experimental variables were then mvestigated in order 
to optimise analytical performance The optimum reaction of 7-OH- 
coumann with its specific antibody takes place at pH 7 3, as determined in 
a previous study [24] Nation was used in the modified electrode 
preparation as it forms an insoluble film and is capable of keepmg the 
protem conjugate immobilised within it Also, the -SO3H groups of Nation 
can dissociate to form -SO3' in aqueous solution and this can repel 
negatively charged species [34] Various concentrations of Nation were 
investigated and a 5% Nation film was shown to be optimum smce lower 
concentrations of it either cracked on drying or resulted in the protem 
conjugate leaching out The effect of the protem conjugate loading 
(thyroglobuhn-7-OH-coumann) m the Nation film is shown in Fig 4 5 In 
this case antibody concentration and temperature of mcubation were kept 
constant The optimum response was achieved using a 15% (w/v) loading 
When higher loadings were mvestigated, the response time of the electrode 
became very slow
The effect of various antibody concentration is shown m Fig 4 6  In this 
case protem loading m the Nation film and the temperature of mcubation 
were kept constant An optimum current response was observed for a 
concentration of 0 33 mg ml~l
The effect of temperature of mcubation on antibody activity was also 
studied with an optimum bemg found near 37 °C, 1 e the temperature 
where most antibodies are shown to bmd to the antigen on the modified 
electrode surface Therefore this temperature was taken as that providing 
maximum antibody activity for the operation of this lmmunosensor
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% (w/v) Thyroglobulin-7-OH-Coumarin
Fig 4 5 Current dependence on thyroglobulin-7-OH-coumann loading in 
the Nafion film upon injection of 1 mM hydrogen peroxide (m the 
presence of 2 mM hydroqumone) The antibody concentration was kept
constant at 0 33 mg ml'l and the temperature was 37°C throughout the 
investigation
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Cone, of antibody (mg per ml)
0.0 0 1 0 2 0.3
Fig 4 6  Effect of anti-7-OH-coumann antibody concentration on 
response to a 1 mM injection of hydrogen peroxide (in the presence of 2 
mM hydroquinone) ThyrogIobuhn-7-OH-coumann loading was kept 
constant at 15 % (w/v) and temperature of incubation was 37°C 
throughout study
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4 3 4 COMPETITIVE ENZYME LINKED ELECTROCHEMICAL 
IMMUNOASSSAY FOR THE DETERMINATION OF 7-OH-
COUMARIN
With these experimental vanables mvestigated, a cahbration curve of 7- 
OH-coumarm was prepared for the immunosensor A competitive 
enzyme-linked electrochemical assay was earned out where both free and 
sohd-phase antigens competitively react for the HRP-labeUed anti-7-OH-
I
coumann antibody (Fig 4 7) After raising with phosphate buffer, the 
enzyme attached to the electrode surface was determined by measuring the 
current after the addition of 1 mM hydrogen peroxide, in the presence of 2 
mM of mediator
The calibration curve of current Vs concentration of 7-OH-coumann is 
shown m Fig 4 8  The response decreases exponentially, as less antibody 
bmds to the immobilised antigen when the concentration of free 7-OH- 
coumann m solution increases Each point on the cahbration curve 
represents the average of three determinations, at a particular 
concentration of free 7-OHC, with its associated error bars From this plot 
7-OH-coumann can be determined between 0 and 1 mM m solution and 
has a limit of detection of 24 pM This range has been shown to be 
physiologically relevant [31,32]
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Surface
Fig 4 7 Diagram of competitive enzyme-linked immunosorbent assay
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Concentration of free 
7-OH-coumarin (mM)
Fig 4 8 Calibration curve for the determination of 7-OH-coumann by 
electrochemical immunoassay Thyroglobulin-7 -OH-coumann loading was
15% (w/v), antibody concentration was 0 33 mg ml'l and the temperature 
of incubation was 37°C for each pomt on the calibration curve
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4.4 CONCLUSIONS
The system described m this paper clearly demonstrates a novel 
electrochemical approach for studying antibody-antigen binding and 
provides a further method for the determination of 7-OH-coumann in 
solution The metabolite can be determined between 0 and 1 mM m 
solution and has a limit of detection of 24 pM In the preparation of the 
modified electrodes it is important to use a protein conjugate which is 
significantly different from the protem conjugate used m the initial 
immunisation of the rabbits Work has since been done to investigate how 
the antibody-antigen interaction on the electrode surface can be reversed 
after a single determination, to produce a modified electrode capable of 
repeated use, for example m flow injection analysis or high performance 
liquid chromatography This was achieved by rinsing the modified 
electrode at the end of the determination m a buffer of low pH, which is 
seen to cleave the antibody-antigen interaction on the electrode surface
[33] Pulsed amperometnc detection can also be used to reverse the 
antibody-antigen interaction, as has been shown by Sadik and Wallace
[23]
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CHAPTER 5
OVERALL CONCLUSIONS
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5.1 OVERALL CONCLUSIONS
The determination of 7-hydroxycoumann m unne and serum by capillary 
electrophoresis was shown to have a number of advantages over existing 
methods for the analysis of this coumann metabolite The capillary 
electrophoresis method was found to be relatively straight forward to use 
and shown to be reliable There was a big advantage gamed over the 
existing HPLC methods m that the separation is much more rapid to run, 
which m the case of analysing numerous samples would prove a 
worthwhile advance
However, there still exists a long sample preparation which takes from the 
advances made here m the separation step This is one area where further 
investigations would need to be done and since this project was 
completed, a capillary electrophoresis method has been developed which 
can analyse 7-hydroxycoumann and 7-hydroxycoumann-glucuromde 
without any sample preparation [1] This now combines a fast 
chromatographic separation with almost no sample preparation One of the 
major drawbacks to working with HPLC is that careful sample preparation 
is required if column degradation is to be avoided especially when working 
with protem solutions This is an area where capillary electrophoresis can 
be very useful in terms of the ruggedness of the technique
Considerable advances were made m the monitoring of 7- 
hydroxycoumann formation in liver microsomes by capillary 
electrophoresis This relatively new analytical technique (m comparison to 
HPLC) was utilised to momtor the formation of 7-OHC by human liver
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microsomes without the need to precipitate the microsomal protems before 
analysis What was worth notmg from this metabolism study was that the 
same capillary was used during the entire investigation without a 
noticeable drop m capillary performance The ability to monitor the 
cofactor as the metabolism progressed proved to be interesting and was 
also an advantage over present HPLC technology This study showed that 
the cofactor is involved m a number of cellular processes within the 
microsomes and this ruled out the possibility of designing a biosensor 
which would use NADPH variation as a means of following cytochrome 
P450 reactions The NADP+/NADPH ratio study also showed that it might 
be possible to use this ratio to determine if a compounds metabolism used 
NADPH as the cofactor The stability of NADPH in solution was 
discussed m the metabolism investigations and for future work it would 
have been interesting to identify the impurity near the NADPH migration 
time The use of a diode array detector would help m this regard
The study did show how 7-hydroxycoumann formation could be 
momtored for a number of different human hver microsomes and the 
results were comparable to those m the literature An mterspecies 
investigation of coumann metabolism was also earned out and the findings 
from the work agreed with those of other workers m the area The 
cynomolgous monkey proved to be the species most closely resembling 
the human metabolism of coumann
Electrochemistry also proved useful m the study of hver microsomal 
reactions The investigations m thè anodic region showed the presence of 
oxidation peaks one of which may have been native NADPH in the 
microsomal suspension Further work is obviously needed to conclusively
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show this The work with NADPH did show that this cofactor is needed in 
many cellular processes as was shown in the capillary electrophoresis 
investigations It was difficult to work with the microsomes 
electrochemically since the signals were very faint and future work mto 
trying to amplify these responses would be advantageous In the cathodic 
region a redox couple was detected, without agam being able to prove its 
origins What would be of use for electrochemical investigations is the 
availability of purified cytochrome P450 This would obviously be 
considerably more pure than working with liver microsomes but although 
possible, not many researchers m this area have access to these enzymes 
Another way of possibly amplifying these faint signals is the use of 
mediators which would help in transferring electrons to and from electrode 
surfaces
The immunosensor which was developed for the determination of 7- 
hydroxycoumann demonstrates a novel electrochemical approach for 
studying antibody antigen binding and provides another method for the 
determination of 7-hydroxycoumann in solution It was possible to 
determine the metabolite upto 1 mM and the method had a limit of 
detection of 24 juM One of the disadvantages of the method was that it 
was not possible to use the modified electrode for a number of 
determinations by cleaving antibody-antigen binding after a determination 
This would have been advantageous and has since been achieved by 
rinsing the modified electrode at the end of the determination with a buffer 
of low pH, which is seen to cleave the antibody-antigen interaction on the 
electrode surface [2]
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